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1. Summary
1.1 Abstract
The two 14-3-3 proteins Bmh1 and Bmh2 belong to a large family of dimeric proteins, which 
are conserved in all eukaryotic cells. They have been described as abundant modulators and 
linked to a broad range of essential cellular processes. 14-3-3 isoforms are highly  similar in 
their structure and thought to have a least partially overlapping functions.
One role of 14-3-3 proteins is to facilitate forward transport of multimeric membrane proteins. 
Recent work in our group has revealed an isoform specific function for the yeast 14-3-3 
isoform Bmh1. However, the mechanism by which only  14-3-3 Bmh1, but not Bmh2, 
promotes forward transport is not known.
In this work, I focus on the investigation of the mechanism that causes isoform specificity  of 
14-3-3 proteins in the forward transport of multimeric membranes proteins. I chose a well 
defined reporter system in Saccharomyces cerevisiae, that allowed me to combine qualitative 
and quantitative methods.
My results show that different steady-state localizations of the reporter are due to differences 
in ER export efficiency, because formation of COPII coated vesicles is less efficient in a 
∆bmh1 background.
Both yeast 14-3-3 proteins were shown to interact with the COPII component Sec23. 
Mutating a putative 14-3-3 binding site in Sec23 resulted in mislocalization of cycling 
proteins in vivo. Furthermore, 14-3-3 Bmh1 was found to fulfill its stimulatory role through 
its distal C-terminal region. Pulldown studies with Bmh1 and Bmh2 C-termini identified a 
nucleoside diphosphate kinase (Ndk1) as a new interaction partner of yeast 14-3-3 proteins. In 
vitro packaging assays were used to demonstrate that  Bmh1 and Ndk1 act at the level of 
vesicle formation from ER membranes. In contrast, a dominant negative role of Bmh2 in 
complex with Ndk1 was discovered.
I speculate, that 14-3-3 proteins in combination with Ndk1 might influence transport kinetics 
of cycling proteins by structural regulation of  COPII vesicles.
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1.2 Zusammenfassung
Die beiden Proteine Bmh1 und Bmh2 aus der Bäckerhefe gehören der grossen 14-3-3 
Proteinfamilie an. 14-3-3 Proteine sind konserviert  in allen eukaryotischen Zellen und haben 
die Eigenschaft als Dimere aufzutreten. Sie wurden als weiterverbreite Modulatorproteine 
beschrieben und mit einer Vielzahl verschiedener, essenzieller Zellvorgänge in Verbindung 
gebracht. Die verschiedenen Isoformen der 14-3-3 Familie weisen eine sehr ähnliche Struktur 
auf und man nimmt an, dass sie zumindest teilweise überlappende Funktionen haben und 
oftmals eine Isoform durch eine andere ersetzt werden kann.
Eine der vielen Rollen von 14-3-3 Proteinen liegt in der Unterstützung des Forwärtstransports 
von multimeren Membranproteinen. Neueste Erkenntnisse aus unserer Arbeitsgruppe zeigten 
eine isoformspezifische Funktion der 14-3-3 Bmh1 Isoform auf. Der isoformspezifische 
Funktionsmechanismus jedoch blieb bisher unerklärt. 
Der Fokus meiner Arbeit liegt in der Aufklärung des isoformspezifischen 
Funktionsmechanismus, der verantwortlich ist dafür, dass die Bmh1 Isoform, nicht aber 
Bmh2, den Vorwärtstransport von multimeren Membranproteinen fördert.
Mit Hilfe eines gut charakterisierten Reportersystems in Saccharomyces cerevisiae war es mir 
möglich,  qualitative und quantitative Methoden zu kombinieren.
Meine Ergebnisse zeigen, dass die Gleichgewichts-Lokalisation des gewählten 
Reporterproteins durch Regulation des Austritts aus dem ER (Endoplasmatisches Retikulum) 
zustande kommt. Die Bildung von COPII Vesikeln am ER war weniger effizient in einem 
∆bmh1 Stamm, als im Wildtyp-Stamm. 
Die Interaktion zwischen der COPII Komponente Sec23 und beiden 14-3-3 Proteinen wurde 
nachgewiesen. Mutationen in einem putativen 14-3-3 Bindungsmotif in Sec23 führten zur 
fehlerhaften Lokalisation von zirkulierenden Membranproteinen in vivo.
Desweiteren wurde der C-Terminus von Bmh1 als die Region identifiziert, die für den 
isoformspezifischen Effekt verantwortlich ist. Pulldown-Versuche mit den C-Termini von 
Bmh1 und Bmh2 führten zur Identifizierung von Ndk1, einer Nukleosid-Diphosphat-Kinase, 
als neuen Interaktionspartner für die 14-3-3 Isoformen in Hefe. Mit Hilfe von in vitro COPII-
budding-assays konnte ich zeigen, dass Bmh1 und Ndk1 zusammen die Bildung von COPII-
Vesikeln an der ER Membran fördern. Im Gegensatz dazu wurde ein dominant negativer 
Effekt für Bmh2 im Komplex mit Ndk1 entdeckt.
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Ich spekuliere, dass 14-3-3 Proteine in Kombination mit Ndk1 den Transport von 
zirkulierenden Proteinen über strukturelle Regulation der COPII-Vesikelbildung regulieren.
3
2. Introduction
Proteins are involved in all cellular processes. The variety of protein functions is made 
possible by their amino acid composition and their three-dimensional shape. Proteins often 
function through binding to other molecules. Specificity  in ligand binding and binding 
kinetics define all cell functions. Whilst many  protein-protein interactions use surfaces unique 
to the interacting molecules, other interactions rely  on adaptor proteins that recognize 
domains or motifs found in a large group  of otherwise unrelated proteins. Adaptor proteins 
can facilitate protein-protein interactions by  bringing two interaction partners into close 
proximity. They can exert regulatory  functions by favoring certain conformations or by 
masking binding sites for other proteins. 14-3-3 proteins are a good example of a class of 
adaptor proteins with a stunning variety of more than 200 interaction partners for which they 
act as scaffolding, regulatory or masking proteins.
In this study two members of the large family of 14-3-3 proteins were investigated with 
respect to their specific function in promoting the forward trafficking of multimeric 
membrane proteins. 
2.1 14-3-3 proteins
14-3-3 were first discovered in a systematic classification of brain proteins (Moore et al., 
1967). The family of 14-3-3 proteins contains a large number of isoforms in mammalian cells 
(beta, eta, epsilon, gamma, sigma, tau and zeta), two in yeast (Bmh1 and Bmh2), 15 isoforms 
in plant cells and two in D. mellanogaster and C. elegans. All isoforms are highly similar in 
their sequence. Similarity ranges from 60% between 14-3-3 sigma and epsilon and 81% 
similarity between the two yeast isoforms to over 90% for C. elegans isoforms. All 14-3-3 
proteins share the common structure of nine alpha-helices which are arranged into groups of 
two, two, two and three (Rittinger et al., 1999). One striking feature of all 14-3-3 isoforms is 
their ability to form homo- and heterodimers through interactions of helices αA to αD (see 
Figure 1; Xiao et  al., 1995, Liu et al., 1995). Helices αC, αE, αG and αI form a peptide 
binding groove that is positively  charged due to the presence of two arginine residues. The 
best described interactions involve 14-3-3 binding to phosphorylated binding motifs on a 
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large variety of target proteins. Three motifs of different consensus were classified as mode-I, 
mode-II and mode-III (see Fig. 24, page 68 for overview). Besides phosphorylation-
dependent binding, 14-3-3 were shown to bind non-phosphorylated motifs as well (van Zeijl 
et al., 2000; Wilker und Yaffe, 2004; Yuan et al., 2003). Hence 14-3-3s are extremely versatile 
proteins that  were found to be involved in various different cellular processes like signal 
transduction, metabolism, DNA damage response and many more (Mackintosh, 2004; Yaffe, 
2002; Tzivion und Avruch, 2002; van Hemert et  al., 2001). In total, over 200 interaction 
partners have been identified for 14-3-3 proteins (Pozuelo Rubio et al., 2004). However, the 
molecular mechanisms of how 14-3-3 proteins participate in these reactions are mostly not 
understood. Especially the question of isoform specificity has not been addressed in detail in 
most cases. 
The large number of isoforms provokes several open questions: Is heterodimerisation 
controlled? And if, how? Where are individual isoforms expressed? Do 14-3-3 isoforms have 
overlapping or specific functions (see Yaffe et al., 2002 for review) ?
Figure 1: 14-3-3 dimer formation
Two 14-3-3 monomers form a homodimer through 
interactions of their N-terminal regions (blue alpha-
helices αA to αD). Dimerization creates a aperture 
ring in the central interaction area (marked by 
circle).
(Yang et al., 2006)
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2.2 The role of 14-3-3s in protein transport
14-3-3 proteins have been demonstrated to influence protein localization by sequestering the 
protein in a subcellular compartment until 14-3-3 binding is abolished (see Fig. 2; Dougherty 
and Morrison, 2004). The common mechanism seems to be masking of localization motifs. 
This includes proteins that are involved in Ras and heterotrimeric G-protein signaling. Here, 
cytosolic 14-3-3 binding masks interaction regions, that are required for localization of the 
proteins to the plasma membrane 
(Dhillon et al., 2002; Ory et al., 2003; 
Niu et al., 2002). In the case of 
mitochondrial and nuclear localized 
proteins, 14-3-3 binding masks 
subcellular targeting sequences. 
However, 14-3-3 proteins were also 
shown to influence targeting of proteins 
which traffic along the secretory 
pathway. After co- t ransla t ional 
integration into the ER membrane, most 
of these proteins are processed at  ER 
exit sites and packaged into COPII 
vesicles. 14-3-3 proteins have been 
found to contribute to the cell surface 
expression of several multimeric membrane proteins (see Table 1 for detailed overview). 
These proteins share the commonality to expose a coatomer protein complex I- (COPI-) 
interacting motif in addition to a 14-3-3-binding motif. The two interaction sites can overlap, 
or be very close to each other, so that  the simplest model proposes masking of the COPI 
signal to prevent retrograde transport of the protein back to the ER, thereby allowing efficient 
forward transport. However, export  of multimeric membrane proteins seems to be very  well 
controlled and direct confirmation of the masking hypothesis is lacking so far. Recent work 
on K+ channels TASK-1 and TASK-3 has revealed a new C-terminal tri-basic motif just next 
to a previously described 14-3-3 mode-III binding site, that when masked by  14-3-3, leads to 
ER exit (O’Kelly and Goldstein, 2008; Zuzarte et al., 2009). Although the masking hypothesis 
seems very logical and simple, O’Kelly and Goldstein in contrast suggested that masking 
Figure 2: 14-3-3s regulate protein localization.
Overview of proteins, whose localization is influenced by 
14-3-3 protein binding.
(Dougherty and Morrison, 2004)
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a COPI binding motif at the N-terminus of TASK-1 and a regulatory role of 14-3-3 at the C-
terminal mode-III binding site are required for TASK-1 export (see discussion for additional 
detail).
For other multimeric membrane proteins, like the KATP-forming subunits SUR1 and Kir6.2, 
binding of 14-3-3 depends on the multimeric presentation of an Arg-based motif (LRKR). 
Yuan and colleagues showed that tetrameric exposure of the last 36 amino acids of the Kir6.2 
subunit, containing the Arg-based motif increases the preference for 14-3-3 binding, whereas 
the monomeric tail bound COPI instead (Yuan et al., 2003). In their studies with the 
Table 1: Membrane proteins that interact with 14-3-3 proteins.
(from Mrowiec and Schwappach, 2006)
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KATP-channel complex, Heusser and colleagues demonstrated that  14-3-3 binding promotes 
surface expression of only correctly  assembled membrane protein complexes. This result 
underlines the role of 14-3-3 proteins as an important factor in the quality-control mechanism 
(Heusser et al., 2006; see Ellgard and Helenius, 2003 for review). To understand the 
interaction between Arg-based motifs in the KATP subunits and 14-3-3 proteins in more detail, 
Michelsen et al moved from mammalian cells to the yeast system. Using the last 36 amino 
acids of Kir6.2 fused to a multimeric Pmp2 reporter protein (ccPmp2-LRKR),  Michelsen and 
colleagues could show that knockout of one isoform (Bmh1), but not the other, lead to 
accumulation of the multimerised reporter protein in the ER (see Fig. 3). In contrast, presence 
of Bmh1 alone was sufficient for very effective export of the reporter protein from the ER.
Different models for the mechanism by which 14-3-3 proteins can modulate forward transport 
of multimeric membrane proteins have been discussed (see Fig. 4; Shikano et al., 2006; 
Mrowiec and Schwappach, 2006 for review).
Yuan and colleagues proposed a simple masking mechanism by which 14-3-3 proteins interact 
with Arg-based motifs only  when exposed in a multimeric fashion. This links 14-3-3 to 
channel assembly, but the details of this interaction and its mechanistic consequences for 
channel trafficking have not been described yet.
both 14-3-3 present:
some ER exit
only Bmh2 present:
NO ER exit
only Bmh1 present:
efficient ER exit
Figure 3: Trafficking of ccPmp2-LRKR reveals 14-3-3 isoform specificity.
Life cell imaging of the ccPmp2-LRKR-YFP fusion protein. The reporter protein localizes mostly in vaculole in 
wildtype cells, indicating ER exit. Knockout of Bmh1 (∆bmh1),  meaning only Bmh2 is present, leads to 
accumulation of ccPmp2-LRKR-YFP protein in the ER. In contrast, the reporter leaves the ER very efficiently in 
the ∆bmh2 strain, demonstrating the stimulatory role of Bmh1 in forward transport.
(Michelsen et al., 2006)
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A major aim of my work was to investigate by which mechanism 14-3-3 binding to the Arg-
based motif leads to forward transport.
Fig 4: Hypothetical mechanisms for 14-3-3-dependent trafficking to 
the cell surface.
(A) Clamping: 14-3-3-binding alters the conformation of the cytosolic 
domain of the membrane protein resulting in the removal of a peptide 
sorting motif from its active zone.
Shikano and Li (2003) showed that functionality of C-terminal di-lysine  
(-KKXX) and Arg-based ER localization signals depends on different 
zones of membrane proximity. Thus, conformational changes introduced 
by 14-3-3 binding could switch the signal between the active and 
inactive state.
(B) Masking: 14-3-3 proteins sterically block access of the COPI coat 
complex to the cytosolic regions of the membrane protein that are in 
contact with 14-3-3. 
Although masking is the most elegant explanation, recent work on the 
TASK-1 K+ channel by Zuzarte and colleagues and OʼKelly and 
Goldstein raised a controversy whether masking is sufficient  to explain 
the role of 14-3-3 proteins in TASK potassium channel forward transport. 
OʼKelly and Goldstein suggest an additional, regulatory role for 14-3-3 
proteins instead of simple masking. This demonstrates that the 
understanding of  the role of 14-3-3 proteins in K+ channel trafficking is 
far from complete. 
(C) Scaffolding: 14-3-3 proteins recruit additional machinery to the 
membrane protein. Protein X could functionally inactivate the COPI coat 
or recruit components required for forward transport.
OʼKelly and Goldstein (2008) described the requirement  for 14-3-3 as 
scaffold proteins to recruit p11 to the C-terminal tail of TASK-1 K+ 
channels. Both proteins were necessary to form a ternary complex with 
the channel. p11 then acts as a modulator protein to enhance surface 
expression. 
(adapted from Mrowiec and Schwappach, 2006)
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2.3 The secretory pathway
The secretory pathway is a network of functionally  and structurally different compartments in 
eukaryotic cells. It allows the cell to process and modify proteins and to communicate with its 
environment through sequential secretion of proteins. Entry point of the secretory pathway is 
the ER (endoplasmatic reticulum). The ER surrounds the nucleus and spreads out widely into 
the cell. It is present as smooth and rough ER. Latter being ER that  is covered with ribosomes 
which facilitate protein synthesis and protein entrance through the translocon complex 
(Gorlich and Rapoport, 1993). Inserted proteins undergo a number of modifications in the 
lumen of the ER: asparagine-linked glycosylation (N-glycosylation), disulfide bond formation 
and protein folding. Chaperones, like the Hsp70 family, control protein folding and stabilize 
unfolded proteins (see Bukau et al., 2006 for review). ER associated degradation (ERAD) of 
Figure 5: Overview of the secretory pathway.
Proteins enter the secretory pathway at the ER. They are transported by COPII to the ERGIC/VTC where 
proteins are concentrated and further transported to the cis-Golgi network. Retrograde transport back to the ER is 
carried out  by COPI vesicles, that can also facilitate protein trafficking between Golgi stacks. Clathrin-coated 
vesicles (CCVs) take over from the trans-Golgi network and deliver the protein to its final destination. In addition, 
CCVs are responsible for endocytosis at the plasma membrane. (adapted from Kirchhausen et al., 2000)
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missfolded proteins can be modulated by chaperones as well, to control folding capacity of 
the ER lumen and to prevent protein aggregation. Correctly folded proteins leave the ER 
through so called ER-exit-sites (ERES), or transitional ER (tER), where cargo is concentrated 
and packaged into COPII (Coat-protein-complex II) vesicles (Orci et al., 1986; Hughes and 
Stephans, 2007 for review). Quality  control mechanisms are applied at ER exit sites to 
guarantee proper assembly of proteins (Mezzacasa and Helenius 2002). This includes 
multimeric membrane proteins as well: The ER export of KATP channel subunits is coupled to 
proper assembly of the heterooctamer. Furthermore, 14-3-3 proteins have been proposed to 
monitor assembly of multimeric membrane protein subunits (Zerangue et al., 1999; Yuan et 
al., 2003). Recent studies suggest that ER exit sites are dynamically regulated to 
accommodate different cargo and to respond to changing demands on cargo flux (Aridor et 
al., 1999; Aridor and Balch, 2000; Guo and Linstedt, 2006; Farhan et al., 2008; Higashio et 
al., 2008).
Formed COPII vesicles transport the cargo via the ERGIC (ER-golgi-intermediate-
compartment; Saraste und Kuismanen, 1984), also described as VTC (vesicular-tubular-
clusters; Balch et al., 1994), to the cis-Golgi network. This compartment is formed of flexible, 
connected membrane stacks. On its way  from cis- to trans-Golgi the protein undergoes 
additional modifications like O-glycosylation. Sorting from the trans-Golgi membrane is very 
versatile and delivers cargo to endomembrane compartments like the lysosome/vacuole or to 
the plasma membrane. 
Three different vesicles transport cargo along the secretory pathway: COPI, COPII and 
Clathrin-coated vesicles (CCVs; see Table 2 for general comparison). The formation of these 
vesicles has in common that small GTP-binding proteins (Sar1 for COPII, Arf1 for COPI and 
Arf1/6 for Clathrin-coated vesicles) initiate recruitment of coat components to the donor 
membrane. These coat proteins then capture and concentrate cargo and generate local 
membrane curvature, leading to vesicle fission (see Lee et al., 2004 for review). GTP 
hydrolysis stimulates fission of the vesicle from the donor membrane. When the target 
membrane is reached, vesicle tethering and fusion is promoted by SNARE proteins.
The COPI coatomer complex is primarily  responsible for retrograde transport of proteins from 
the cis-Golgi back to the ER (Letourneur et al., 1994). Recognition of ER-sorting motifs like 
the C-terminal dilysine motif -KKXX (Nilsson et al., 1989), -WXXW (Cosson et al., 1998) 
and Arg-based -LRKR-motifs by  the coat, sorts membrane proteins into COPI-coated vesicles 
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(Zerengue et al., 1999). It was shown, that the COPI complex can act in quality control to 
bring improperly assembled KATP channel subunits back to the ER to allow a new round of 
assembly  (Yuan et al., 2003; Michelsen et al., 2005; Mrowiec and Schwappach, 2006 for 
review).
Clathrin-coated vesicles (CCVs) are the best studied class of vesicles and can bud from 
plasma membrane as well as the trans-Golgi network and facilitate endocytosis and transport 
between lysosomes, endosomes and the trans-Golgi network (Kirchhausen, 2000 for review). 
The variety of transport routes is achieved by  interactions with different adaptor proteins 
(Hirst et al., 1999). The major component of CCVs is clathrin: Three heavy chains (CHC) and
three light chains (CLC) form a so called triskelion that defines the outer coat of CCVs 
(Ungewickell und Branton, 1981).
COPII vesicles form at ER membranes and transport cargo proteins to the cis-Golgi network. 
Since these vesicles are of major interest in this study, they will be discussed in the following 
section in more detail.
Transport/
Component
COPII COPI Clathrin
Transport ER to cis-Golgi - cis-Golgi to ER
- between Golgi stacks
- trans-Golgi to plasma 
membrane and to late 
endosome
- between endosome 
and lysosome
- endocytosis
GTPase Sar1 Arf1 Arf1 (AP1/3/4), Arf6 
(AP2)
Guanine-exchange 
factor (GEF)
Sec12 Sec7-like proteins, 
GBF1
Sec7-like proteins
GTPase-activating 
protein (GAP)
Sec13/31, Sec23/24 Coatomer ?
Inner-coat complex Sec23/24 beta/delta/gamma/
zeta-Coatomer 
subunits
AP1-4
Outer-coat complex Sec13/31 alpha/beta’/epsilon-
Coatomer subunits
Clathrin
Table 2: Comparison of general aspects of COPII, COPI and CCVs.
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2.4 COPII transport in the secretory pathway
Barlowe and colleagues discovered COPII-coated vesicles in genetic studies of temperature 
sensitive Saccharomyces cerevisiae strains defective in ER export (Barlowe et al., 1994). 
Since then, enormous progress has been achieved to understand the mechanisms that underlie 
COPII formation. Budding of a COPII vesicle at the ER membrane is initiated by the small 
GTPase Sar1. The cyctosolic GDP-bound form of Sar1 first  binds its membrame bound 
interaction partner Sec12. Sec12 is a guanine exchange factor (GEF) that catalyses GDP to 
GTP exchange on Sar1 (Barlowe et al., 1993; Barlowe and Schekman, 1993). GTP binding 
leads to exposure of an N-terminal amphipathic α-helix into the ER membrane (Goldberg, 
1998 ; Bi et al., 2002) that anchors Sar1 in the membrane. Membrane bound Sar1 then 
recruits coat components in two steps: First, the inner coat components Sec23 and Sec24 are 
recruited. Cargo selection and binding occurs most likely by Sec24. Multiple cargo binding 
domains have been identified in Sec24 that  suggest specific cargo selection by  inner coat 
components (Miller et al., 2003; see Mancias and Goldberg, 2005 for review). Recent studies 
of the X-ray structures of the four human Sec24 proteins revealed specific sites in Sec24a and 
Sec24b that were absent in Sec24c and Sec24d and allowed selective cargo binding (Mancias 
and Goldberg, 2008). Binding of correctly  assembled cargo proteins can enhance affinity  to 
Sec24, thus stabilizing the inner coat formation and allowing more time for recruitment of 
outer coat components Sec13 and Sec31. This could be one mechanism of cargo 
concentration and could function as a proofreading mechanism (Sato and Nakano, 2007). 
Insertion of Sar1-GTP into the membrane and binding of the bowtie-shaped Sec23/24 
complex introduces membrane curvature that is absolutely required for vesicle formation 
(Farsad and De Camilli, 2003; Lee et al., 2005). Recent work by Stagg and colleagues 
suggests a Sec23/24-cargo ternary  prebudding complex that needs to be formed first to allow 
recruitment of Sec13/31 (Stagg et al., 2008). Sec13/31 are thought to function as structural 
scaffold, that  stabilizes the Sar1-Sec23/24-prebudding complex and enhances membrane 
curvature (Stagg et al., 2006). New structural insights have revealed that the outer coat is 
capable of forming COPII vesicles of different shape and size. This strongly enhances the 
flexibility of coat geometry  and allows even very large vesicles to be packaged (Stagg et  al., 
2006; Stagg et al., 2008). Still, the observed maximum angle for the flexible hinge region 
between Sec13 and Sec31 is sufficient for vesicles up  to 1000 Å. However for very  large 
cargoes such as procollagen, even vesicles of this size are not sufficient. 
13
Sequential addition of COPII coat components suggests a stepwise increasing GAP (GTPase-
activating protein) activity  that stimulates GTP hydrolysis on membrane bound Sar1-GTP and 
facilitates the release of a formed COPII vesicle (Lee et al., 2004). Thus, binding of the 
Sec13/31 complex was shown to accelerate the Sec23-mediated GAP activity (Antonny et al. 
2001). However, as shown by  Antonny and Schekman, GTP hydrolysis is not  required for 
vesicle fission, since budded vesicles could be observed by using the nonhydrolysable GTP 
analogue (GTPγS) (Antonny and Schekman, 2001).
Figure 6 summarizes the steps required to form a COPII vesicle. 
Multimerisation of the Sar1/Sec23/24-cargo complex, the flexible hinge region in Sec13/31 
and its contact with the inner membrane coat are highly plausible putative interaction targets 
for regulatory  factors. 14-3-3 proteins have been previously  reported to interact with Sec23 
(Pozuelo Rubio et al., 2004). One aspect of my thesis was the investigation of a putative role 
of yeast 14-3-3s as regulatory factors of COPII budding.
Figure 6: Cartoon of COPII vesicle formation.
The guanine exchange factor (GEF) Sec12 catalyses the exchange of GTP for GDP on the cytosolic Sar1 
protein.  This leads to binding of Sar1-GTP to the ER membrane and recruitment of the Sec23/24 complex. Cargo 
selection by Sec24 keeps the inner coat (Sar1-Sec23/24) stable and allows binding of the outer coat components 
Sec13/31. Sec13/31 is able to form flexible vesicle cages around the inner coat which in combination with Sar1 
membrane insertion and the Sec23/24 bowtie-shaped structure leads to vesicle formation. GTPase-activating 
protein activity by Sec23 and Sar1 itself finally leads to release of the COPII vesicle.
(Figure from Sato and Nakano, 2007)
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2.5 Trafficking of KATP channels
ATP sensitive potassium channels (KATP channels) were first  identified in 1983 by  Noma and 
found to be present in many tissues, such as the pancreas (Ashcroft et al., 1984). They 
function as inwardly rectifying potassium channels and play  crucial roles in important cellular 
processes like the insulin secretion from pancreatic β-cells (Cook et al., 1988; Ashcroft and 
Rorsman, 1989). Increasing glucose concentration in the cell leads to production of ATP in the 
cytosol. ATP inhibits the KATP channel (Babenko et al., 1998) and leads to membrane 
depolarization through altered membrane potential. Influx of calcium through the now 
activated Ca2+ channels facilitates exocytosis of insulin containing granules that once fused to 
the plasma membrane, release insulin to lower glucose levels in the blood stream (Miki et al., 
1999). 
KATP channels are present as an octamer formed by two groups of four subunits each. The first 
group is built by four units of the sulphonylurea receptor 1 (SUR1) which is a member of the 
ATP-binding cassette (ABC) membrane transporter superfamily. Four SUR1 form the 
regulatory part of the channel. The pore-forming domain of KATP channels is composed of 
four units of inwardly rectifying potassium channels (Kir6.x). The composition of KATP 
channels in pancreatic β-cells is shown in Figure 7. 
A
B
Figure 7. Composition of a KATP channel in pancreatic β-
cells.
(A) Four regulatory SUR1 (sulphonylurea receptor) subunits 
and four pore-forming Kir6.2 (inwardly rectifying potassium
channel) subunits form the KATP channel in pancreatic β-
cells.
The channel is inserted in the membrane through 17 
transmembrane domains (TMD) in each SUR subunit and 
two TMDs in each Kir6.2 subunit.
(modified from Zerangue et al., 1999).
(B) Topology of Kir6.2 and SUR1.
C-terminal loops are exposed into 
the cytoplasm in both subunits. 
These regions contain the Arg-
based motif (highlighted in red), 
which was identified to be a binding 
motif for COPI and 14-3-3 proteins 
(Yuan et al., 2003).
(modified from Michelsen et al., 
2005)
15
A distinct feature of the KATP channel formed by SUR1 and Kir6.2 is that both subunits 
expose a Arg-based motif (LRKR-motif) in the cytosolic regions (see Fig. 7 B). Schwappach 
and colleagues could show that these signals retain single subunits in the ER until correct 
assembly  of the octameric channel occurs (Schwappach et al., 2000; Zerengue et al., 1999). 
Further investigations by Yuan and colleagues identified binding of 14-3-3 proteins to the 
LRKR-motif. Using the last 36 amino acids of the Kir6.2 subunit they demonstrated that 
14-3-3 proteins bind preferentially to multimeric versions of the tail containing the LRKR-
motif. On the other hand, monomeric presentation, mimicking unassembled channel subunits, 
lead to strong binding and retrieval by the COPI machinery (Yuan et al., 2003; Michelsen et 
al., 2007). The resulting model is shown in Figure 8.
Figure 8. Model of the KATP channel transport.
SUR1 subunits are displayed as L-shaped structure. Kir6.2 subunits as rectangular structures. Red dots 
symbolize the Arg-based LRKR-motif exposed by both subunits.
14-3-3 proteins bind to multimeric presentation of  the LRKR motif and mask the motif, so that COPI retrieval can 
not occur. Monomeric presentation leads to retrograde trafficking back to the ER by the COPI machinery.
According to this model 14-3-3 and COPI create a quality control mechanism since only properly assembled 
channels (octamers of four SUR1 and four Kir6.2) reach the plasma membrane (Yuan et al., 2003).
Presence of a di-leucine signal is involved in endocytosis of the channel from the plasma membrane.
(modified from Michelsen et al., 2005)
Kir6.2 subunit
SUR1 subunit
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2.6 Aims of the thesis
Yuan et al identified two mammalian 14-3-3 isoforms to interact with a multimeric version of 
the last  36 amino acids of the C-terminal Kir6.2 tail. Using mammalian cells, a general 
regulatory function of 14-3-3 proteins could be defined. However, to gain mechanistic 
insights into isoform specific binding and regulation of KATP channel trafficking by  14-3-3 
proteins the yeast system offers key benefits: (1) Only two 14-3-3 isoforms (Bmh1 and 
Bmh2) are present in yeast, in comparison to seven in mammalian cells. (2) Knockouts are 
available in the form of a ∆bmh1, a ∆bmh2 and a viable ∆bmh1∆bmh2 strain.
For these reasons, Michelsen and colleagues made use of a Pmp2 reporter protein that was 
fused to the last 36 amino acids of Kir6.2 containing the Arg-based motif and a fluorescence 
reporter (see Fig. 9). KATP channel assembly was simulated by  multimerization of the tail 
through addition of an GCN4 leucine zipper variant pLI (Harbury et al., 1993). Monitoring 
the localization of the Pmp2 reporter, Michelsen et  al demonstrated an isoform specific role of 
Bmh1 in forward trafficking (see Fig. 3).
Figure 9: Cartoon of the tetrameric Pmp2 fusion protein.
The 38 amino acids long isoproteolipid Pmp2 is a yeast 
membrane-bound regulator of  the plasma membrane proton 
pump  (Navarre et al., 1994). The protein was fused to a 
GCN4 leucine zipper, a fluorescence marker like YFP or 
GFP and the last 36 amino acids of Kir6.2 containing the 
Arg-based LRLR motif (highlighted in red). Tetramerization 
of four fusion proteins is caused by the GCN4 leucine zipper 
and mimics the assembly of KATP channels.
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I made use of yeast as a model to test  several hypotheses for the mechanism of 14-3-3 
dependent sorting in eukaryotic cells.
The following questions were the main focus of my thesis. To tackle them I combined yeast 
live cell imaging, site-directed mutagenesis of the 14-3-3 proteins and an in vitro COPII 
budding assay with biochemical methods.
• How can two 14-3-3 isoforms that share 81% similarity  show isoform specific 
behavior? What are the mechanistic details that create isoform specificity?
• At which step(s) of the forward trafficking process do 14-3-3 proteins act?
• Can simple masking of the Arg-based COPI recognition motif by 14-3-3 proteins 
explain that Bmh1 but not Bmh2 promotes forward transport?
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3. Materials and methods
3.1 Materials
3.1.1 Reagents and kits
Reagent / Kit Company
Agar Melford
Amino acid mix (CSM) BIO 101
Amino acids: L-Arginine, L-Histidine, L-
Leucine, L-Tryptophan
BIOMOL
Amino acids: L-Methionine, Uracil Sigma
Biomate 5 (UV-Vis spectrophotometer) Thermo scientific
Bradford Reagenz Protein Assay BioRad
Complete® Protease Inhibitor (+/- EDTA) Roche
CSM amino acid powder (lacking Ade, His, 
Leu, Met, Trp, Ura)
Q-BIOgene
Drop-out mix synthetic US Biological
ECL™ Western Blotting Detection Reagents Amersham Biosience
ER-Tracker Molecular Probes
Factor Xa Amersham
GSH-Agarose Sigma
High Pure PCR Product Purification Kit Roche
Hybond™-ECL™ Nitrocellulose membrane Amersham Bioscience
IgG Sepharose 6 Fast Flow GE Healthcare
ImmunoPure® Immobilized Protein A/G Pierce
MobiCols Filtertubes 35µm pore size MoBiTec
Peptone Melford
Protino Ni-NTA 2000 Macherey-Nagel
QIAprep Spin Miniprep Kit QIAGEN
Tryptone Melford
UVI doc UVITEC
Yeast extract Melford
Yeast nitrogen base w/o amino acids BD
YeaStar Genomic DNA Kit Zymo Research
Other chemicals used in this study were purchased from Sigma,  Roth,  Roche,  Serva, 
Merck,  USB, AppliChem,  J.T.Baker,  Boehringer, Biomol,  Amersham,  Molecular Probes, 
Bio-Rad.
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3.1.2 Enzymes
Restriction enzymes Company
AatII; AgeI; ApaI
BamHI; BglI; BglII; Bsp120I
EcoR I; EcoR V
Hind III; HpaI; KpnI;
NcoI; NdeI; NheI; MluI; NotI; NsiI
PmeI; PstI
SacI; SalI; SmaI; SphI
XbaI; XhoI
Fermentas und New England Biolabs
Enzymes used for manipulation of DNA Company
CIAP (Calf Intestine Alkaline Phosphatase) Fermentas
Expand High Fidelity DNA polymerase
thermo stabile
Roche
Pfu DNA polymerase thermo stabile Fermentas
Taq DNA polymerase thermo stabile Schwappach lab
T4-DNA ligase Fermentas
T4-DNA polymerase Fermentas
Other enzymes Company
ImmunO Zymolyase MP Biomedicals
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3.1.3 Media and antibiotics for bacterial cultures
Medium / antibiotic Preparation
SOC medium
Add 1 ml 40% glucose and 1 ml MgCl2 to 100 ml of the 
following medium:
Per liter: 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 2.5 ml 
1 M KCl. Adjust pH to 7.0 with NaOH. Aliquot in 100-ml 
and sterilize by autoclaving.
Luria-Bertani (LB) medium Per liter: 10 g tryptone, 5 g yeast extract, 10 g NaCl. Adjust 
pH to 7.0 with NaOH. Sterlize by autoclaving. Add 
antibiotics if necessary.
Luria-Bertani (LB) agar Per liter: 10 g tryptone, 5 g yeast extract, 10 g NaCl. Adjust 
pH to 7.0 with NaOH. Add 15 g agar before autoclave. Add 
antibiotics if necessary.
2YT medium Per liter: 15 g Trypton, 10 g yeast extract, 5 g NaCl, 2% (v/
v) Glycerine, 30 mM Potassiumphosphate. Sterlize by 
autoclaving. Add antibiotics if necessary.
Ampicilin (Amp) stock Prepare 100 mg/ml stock in MiliQ H2O and sterilize by 
filtration through a 0.22 µm filter. Aliquot and store at –20 
°C. Working concentration was 100 µg/ml.
Kanamycin (Kan) stock Prepare 50 mg/ml stock in MiliQ H2O and sterilize by 
filtration through a 0.22 µm filter. Aliquot and store at –20 
°C.
Doxycycline stock Dissolve doxycycline sulfate (Sigma) in MiliQ H2O to a 
concentration of 1 mg/ml. Sterilize by filtration through a 
0.22 µm filter and store at 4 °C in a light-tight container. 
Make fresh stock every 4 weeks.
Chloramphenicol stock Dissolve chloramphenicol in ethanol to a concentration of 
34 mg/ml. Sterilize by filtration through a 0.22 µm filter, 
aliquot and store at -20 °C.
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3.1.4 Media, antibiotics and solutions for yeast cultures
Medium / antibiotic Preparation
Nourseothricin (CloNat) Prepare 100 mg/ml (1000x) stock solution. Sterilize 
by filtration through a 0.22 µm filter, aliquot and 
store at -20 °C.
G418 (Geneticin) Prepare 200 mg/ml (1000x) stock solution. Sterilize 
by filtration through a 0.22 µm filter, aliquot and 
store at -20 °C.
Yeast full medium (YPAD) Per liter: Dissolve 10 g yeast extract, 20 g Peptone 
in MiliQ H2O. After autoclaving, add 40 mg 
Adenine and 40 ml of 40% Glucose through a 0.22 
µm filter.
Selective yeast medium Per liter: Mix 6.7 g yeast nitrogen base, 0.65 g CSM 
amino acid powder, 20 g glucose, 20 mg of each 
necessary amino acid in MiliQ H2O and sterilize by 
filtration through a 0.22 µm filter.
Yeast plates Dissolve 40 g/l agar in MiliQ H2O and autoclave. 
Combine 50% (v/v) of yeast medium (doubled 
concentration of ingredients) and 50% agar (v/v), 
mix and pour plates.
Lithium acetate solution Prepare a 1 M lithium acetate stock solution, (10x) 
pH 7.5 in MiliQ H2O.
Polyethylene glycol (PEG) solution Prepare a 50% PEG stock solution with PEG 4000 
in MiliQ H2O.
3.1.5 General solutions used in the study
Solution Preparation
Annealing buffer For a 2x solution:  40 mM Tris/HCl, pH 7.6, 
60 mM NaCl.
Western blot blocking solution Dissolve 5% (w/v) milk powder, 0.02% NP-40 
in 1x TBS solution.
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Coomassie staining solution Per 1 liter: Dissolve 2 g Coomassie Brilliant 
Blue in 300 ml ethanol (absolut) and 100 ml 
acidic acid.
Coomassie fixation and destain solution Per 1 liter: Mix 300 ml ethanol (absolut), 100 
ml acidic acid and 600 ml MiliQ H2O.
DNA loading buffer Dissolve 30% (w/v) Ficoll 400, 0.25% (w/v) 
bromophenol blue and 0.25% xylene cyanol in 
MiliQ H2O.
Phosphate buffered saline (PBS) Combine 140 mM NaCl, 3 mM KCl, 8 mM 
Na2HPO4, 1.5 mM KH2HPO4, pH 7.4, ad 1l 
MiliQ H2O.
Ponceau-S Per liter: 20 g Ponceau-S, 300 g trichloroacetic 
acid, 300 g sulfosalicylic acid in MiliQ H2O.
SDS PAGE running buffer Prepare 250 mM glycerin, pH 8.3, 125 mM 
Tris and 0.1% (v/v) of 10% SDS solution, in 
MiliQ H2O for 5x solution.
SDS PAGE sample buffer Prepare 250 mM Tris-HCl, ph 6.8, 50% (v/v) 
glycerin, 5% (v/v) of 10% SDS solution, 0.5% 
(w/v) bromophenol blue and 250 mM 
dithiothreitol (DTT) in MiliQ H2O for 5x 
solution.
10 % SDS Per liter: Dissolve 100 g sodium dodecyl 
sulphate in MiliQ H2O.
T4-ligase buffer Prepare 50 mM Tris-HCl, pH 7.6, 10 mM 
MgCl2, 1 mM ATP, 1 mM DTT, 50 mg/ml 
PEG-8000 in MiliQ H2O for 10x stock 
solution. Aliquot and store at -20 ºC.
TAE - DNA running buffer Prepare 800 mM Tris-HCl, pH 7.5, 200 mM 
Na-acetate, 20 mM EDTA, pH 8 in MiliQ H2O 
for 20x stock solution.
Tris buffer for SDS PAGE stacking gel 1 M Tris-HCl, pH 6.8 for 8x stock solution.
Tris buffer for SDS PAGE seperation gel 1.5 M Tris-HCl, pH 8.8 for 4x stock solution.
TBS Prepare 240 mM Tris-HCl, ph 7.4, 1.36 M 
NaCl, 30 mM KCl in MiliQ H2O for 10x stock 
solution.
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Western blot (semi-dry) transfer buffer Prepare 390 mM glycine, 480 mM Tris, pH 
8.3, 3.7 g/l SDS in MiliQ H2O for 10x stock 
solution. Add 20% (v/v) methanol in 1x 
transfer buffer solution.
Western blot (wet) transfer buffer 10x For a 10x stock solution prepare a solution of 
250 mM Tris, 1.92 M glycine, pH 8.3. Do not 
use HCl for pH adjustment.
Ammonium persulfate (APS) Dissolve 1 g ammonium persulfate in 10 ml 
MiliQ H2O for a 10% stock solution. Store at 4 
°C.
Phenylmethylsulfonyl fluoride (PMSF) Dissolve PMSF in isopropanol, 17.4 mg/ml for 
a 100 mM stock solution. Aliquot and stored at 
-20 ºC.
Isopropylthio-β-D-galactoside stock (IPTG) Dissolve IPTG in MiliQ H2O, 238.3 mg/ml for 
1 M stock solution. Sterilize the solution 
through a 0.22 µm filter. Make 1 ml aliquots 
and store at –20 ºC.
BN-PAGE solubilization buffer A 50 mM NaCl, 50 mM imidazole, 2 mM EDTA, 
2 mM 6-amino-hexanoic acid, pH 7.0
BN-PAGE solubilization buffer B 50 mM imidazole, pH 7.0, 2 mM EDTA, 750 
mM 6-amino-hexanoic acid
3.1.6 Technical equipment used in the study
Equipment Company
Electroporator BioRad
PTC-200, Peltier Thermal Cycler MJ Reaearch
Electrophoresis unit Mighty Small Amersham Bioscience
Hoefer Mighty Small Gel System Hoefer
Sonifier 450 Branson
Biofuge pico centrifuge Heraeus
Ultra centrifuges Beckman
High speed centrifuges Sorvall and Heraeus
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DeltaVision microscope (equipped with a 
100×/0.35-1.5 Uplan Apo objective and a 
Sedat quadruple filter set (Chroma 86000v2))
Leica
Coolsnap HQ camera Photometrics
Biacore 3000 BiaCore
Trans-Blot Cell BioRad
Trans-Blot SD Cell BioRad
3.1.7 Antibodies
Antibody (used concentration) Derived from
Anti-GFP (1:1000) D. Görlich lab
Anti-HA (1:1000 for WB) Covance
Anti-Bmh (1:1000 for WB) This study
Anti-Bmh1 (1:2000) P. van Heusden lab
Anti-Sec61 (1:10000) M. Seedorf lab
Anti-Kir6.2 (1:1000) Schwappach lab
Anti-Sec22 (1:2000) A. Spang lab
Anti-Bos1 (1:2000) A. Spang lab
Anti-Bet1 (1:2000) A. Spang lab
Anti-Sec24 (1:2000) A. Spang lab
Anti-Emp47 (1:2000) H. D. Schmitt lab
Anti-Ndk1 (1:1000) Pain lab
Secondary antibodies: HRP conjugated 
(1:5000)
Jackson Immunoresearch
3.1.8 Bacterial strains used in this study
Strain Genotype
DH5α hdsR17 supE44 ∆lacU169 (F80 lacZ∆M15) recA1 endA1 
gyrA96 thi 1
relA1∆
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BL21 DE3 Star pRosetta ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac[F' proAB lacq Z∆                              
M15 Tn10 (Tetr)]; RNAseE-; pRosetta
3.1.9 Yeast strains used in this study
Strain Genotype Derived from
Euroscarf knockout 
library
COMP-SET 1-A EUROSCARF
TetO7 library Yeast Tet-promoters Hughes Collection (yTHC) Open Biosystems
Y00000
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0
EUROSCARF
Y06173 Δbmh1
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0,
yer177w::kanMX4
EUROSCARF
Y04034 Δbmh2
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0,
ydr099w::kanMX4
EUROSCARF
RRY1249
Δbmh1Δbmh2
Sigma1278b, MATalpha, ura3-52, leu2::hisG,
his3::hisG, bmh2::His3+, bmh1::His3+
Fink lab
RRY1257
WT zu
RRY1249
Sigma1278b, MATa/alpha, ura3-52, his3::hisG,
RED1+, Trp1+/trp1::hisG, Leu2+/leu2::hisG
Fink lab
YKL067W Δndk1
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0,
ykl067w::kanMX4
EUROSCARF
Δndk1 Δbmh1
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0,
ykl067w::kanMX4, yer177w::natMX4
This study
Δndk1 Δbmh2
BY4741, MATa, his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0,
ykl067w::kanMX4, ydr099w::natMX4
This study
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AH109
Mat a, trp1-901, leu2-3, 112, ura3-52, his3-200,
gal4Δ, gal80Δ, LYS2GAL1UAS-GAL1TATA-HIS3,
GAL2UAS-GAL2TATA-ADE2, 
URA3::MEL1UASMEL1TATA-
lacZ, MEL1
Clontech
3.1.10 Plasmids
Plasmid Description Derived from
pJ478 ZZ-cc-LRKRS- in pQE60 Schwappach lab
pJ479 ZZ-cc-LKKKS- in pQE60 Schwappach lab
pJ486 BMH1 in pQE80 D. Görlich lab
PJ487 BMH2 in pQE80 D. Görlich lab
pL588 PMP2-GFP-LRERS- in p416 Schwappach lab
pM628 PMP2-cc-YFP-LRKRS- in p416 Schwappach lab
pM629 PMP2-cc-YFP-LKKKS- in p416 Schwappach lab
pM630 PMP2-cc-YFP-LRKRS- in p415 Schwappach lab
pM643 PMP2-YFP-LKKKS- in p416 Schwappach lab
pM650 PMP2-YFP-LRKRS- in p416 Schwappach lab
pN654 PMP2-YFP-KKXX in p416 Schwappach lab
pL571 PMP2-GFP-KKXX in p416 Schwappach lab
pM653 PMP2-cc-YFP-LKKKS- in p415 Schwappach lab
pG304 GEF1-GFP in p416 Schwappach lab
pT987 14-3-3 H1N2C in p416 This study
pT988 14-3-3 H2N1C in p416 This study
pT972 SEC23-S79N in BFGIII This study
pT973 SEC23-S726N in BFGIII This study
pT986 SEC23-S79N/S726N in BFGIII This study
pT971 SEC23 in BFGIII This study
pJ480 proteinA (2x)-R18 This study
pN681 BMH1 in p416 This study
pS911 PRC1(150bp)-pHluorin in p416 This study
BMH1 C-terminus in pGEX6PI This study
BMH2 C-terminus in pGEX6PI This study
BMH1 C-terminus in pGBKT7 This study
BMH2 C-terminus in pGBKT7 This study
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YNK1 in p416 This study
YNK1-H6 in p416 This study
YNK1-HA3 in pRS416 Pain lab
YNK1-H6 in pET21b Pain lab
SAR1-GST in pGEX-3x A. Spang lab
pYM15 EUROSCARF
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3.2 Methods
3.2.1 Working with DNA
3.2.1.1 Purification of plasmid DNA from bacteria
5 ml of bacterial culture was incubated over night (oN) in the appropriate LB medium with 
antibiotic(s) at 37 ºC. Plasmid DNA was purified using the QIAprep Spin Miniprep  Kit 
(QIAGEN) according to the user manual. Cell lysis is based on alkaline lysis. After 
precipitation of proteins and cleaning from chromosomal DNA and cell trash, plasmid DNA is 
bound to a silica-gel membrane (anion-exchange matrix), washed and eluted using 50 µl of 
MiliQ water (for ligation) or 50 µl of elution buffer (QIAGEN). Plasmid DNA was checked 
by analytical test digestion and sequence analysis (GATC).
3.2.1.2 Purification of genomic DNA from yeast
5 ml of yeast culture were incubated oN in the appropriate selective yeast medium. Plasmid 
DNA was purified using the YeaStar Genomic DNA Kit (Zymo Research) according to the 
manufacturer’s instructions. Cell lysis is based on digestion of the cell wall using R-
Zymolyase (Zymo Research). DNA was purified on a affinity column. 
3.2.1.3 Determination of DNA concentration
DNA concentration was determined by spectrophotometric analysis at  a wavelength of 260 
nm. DNA absorbs UV light at this wavelength and DNA concentration is a direct function of 
the absorbed light. The linear relationship  between absorbance and DNA concentration makes 
it possible to calculate the total DNA concentration as follows:
Unknown mg/ml = 50 µg/ml * Measured A260 value * dilution factor.
3.2.1.4 Restriction digest
Restriction digest was performed according to the standard method described by Sambrook et 
al., 1998.
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1 Unit of restriction enzyme, 2 µg of DNA for plasmid digestion and 2-10 µg of DNA for 
smaller insert fragments were used in a reaction mix of a total volume of 30 µl. Incubation 
time was 1.5 h, incubation temperature and reaction buffer were chosen according to the used 
enzyme(s). To prevent self-circularization of the digested plasmid, 1 Unit  of alkaline 
phosphatase (CIAP, Roche) was added for 20 min at 37 ºC to the plasmid DNA reation mix 
after digestion. 
Blunt ends were created using 5 units of T4 DNA polymerase and 3-5 µg of DNA fragment in 
the presence of 1.2 mM dNTPs (300 µM for each dNTP) at 37 °C for 30 min.
3.2.1.5 DNA gel electrophoresis
DNA fragments were diluted in a 6x DNA loading buffer and separated by agarose gel 
electrophoresis at 50-200 V using 0.8-1.5% agarose gels. DNA was stained using ethidium 
bromide in a concentration of 100 mg/ml in the gel. Visualization was performed using 
ultraviolet (UV) light. A UVIdoc system (UVITEC) was used for documentation.
3.2.1.6 DNA purification from agarose gels
DNA fragments were purified after seperation on a agarose gel by using the High Pure PCR 
Product Purification Kit (Roche). Purification was performed according to the manufacturer’s 
instructions.
Since DNA fragments smaller than 100 bp  are removed in the washing steps of the High Pure 
PCR Product Purification Kit, those small fragments were purified by using the Ultrafree-MC 
Centrifugal Filter Units with Microporous Membrane (0.45 µM, Millipore).
3.2.1.7 Ligation of DNA fragments
Ligation of DNA fragments was performed using the enzym T4-DNA ligase, which catalyses 
the building of phosphodiester bond between two DNA molecules.
In a typical ligation reaction 1-2 units of T4-DNA ligase, 50-100 ng of digested vector and 
insert DNA (in a molar ratio of 3-10 times the vector DNA) were incubated for 16 h at  18 ºC 
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in a ligase specific buffer. T4-DNA ligase was inactivated by incubating the reaction mix for 
10 min at 65 ºC. The ligation product was than ready for transformation.
3.2.1.8 Preparation of competent bacterial cells
One single bacterial colony was picked and inoculated in 20 ml LB medium over night (oN) 
at 37 ºC. 10 ml of the oN culture were diluted in 900 ml LB medium and grown at 37 ºC until 
an OD600 of 0.5-0.7 has been reached. The culture was cooled down on ice and pelleted in 50 
ml tubes (3000 rpm, 5 min at 4 ºC). The bacterial pellet was washed extensively with sterile 
and ice cold MiliQ H2O. In addition, a last washing step with sterile, ice cold 10 % glycerol 
solution was performed to remove all remaining salt in the pellet. Finally, the pellet was 
resuspended in 3 ml of sterile, ice cold 10 % glycerol solution, distributed in 50 µl aliquots, 
immediately frozen in liquid nitrogen and stored at -80 ºC. 
3.2.1.9 Transformation of bacteria
Transformation of bacteria was performed by electroporation with a Gene Pulser II 
electroporator (BioRad).
50 µl of competent bacteria cells (DH5α or BL21) were mixed on ice with 1-2 µl of  ligation 
product, or 1 µl of diluted plasmid DNA (for retransformation) and electroporation was 
performed at  a voltage of 2.5 mV, a resistance of 400 Ω and a capacity  of 25 µF. Bacterial 
cells were diluted in SOC medium and incubated for 45 min at 37 ºC for regeneration. 
Recovered cells were streaked out on LB agar plate supplemented with appropriate 
antibiotic(s) and further incubated at 37 °C until single colonies appeared.
3.2.1.10 Polymerase chain reaction (PCR)
Polymerase chain reaction was performed according to standard protocols as described in 
Lawyer et al., 1989 and Saiki et al., 1988. A typical reaction mix was setup as following:
100 ng  DNA template
0.4 µM  forward primer
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0.4 µM  reverse primer
600 µM  dNTPs (GTP, ATP, TTP and CTP)
5 µl   10x PCR reaction buffer
2.5 units  pfu, Taq, or High fidelity Expand Polymerase
ad 50 µl with MiliQ H2O
A Peltier Thermo Cycler (MJ Research) was used for amplification with a typical PCR 
program as follows:
step description duration temperature
1 initial DNA 
denaturizing
2 min 94 °C
2 DNA denaturizing 20 sec 94 ºC
3 annealing 30 sec calculated temperature (see below)
4 elongation calculated time (see below) 72 ºC
5 repeat steps 2 - 4 25 – 30 cycles
6 final elongation 2 min 72 ºC
7 store PCR product ∞ 4 ºC
The primer specific annealing temperature was calculated using the formula:
Tm -2 °C (Tm =4x(G+C)+2x(A+T)
Elongation temperature was calculated with 1 min per kB of the amplified DNA fragment.
The PCR product was processed as described in 3.2.1.5 and 3.2.1.6.
3.2.1.11 DNA sequencing
To confirm correctness of manipulated DNA molecules, samples were sent out to GATC 
GmbH for sequencing and verified.
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3.2.2 Biochemical methods
3.2.2.1 Protein expression in bacteria
3.2.2.1.1 Expression of untagged 14-3-3 proteins
14-3-3 isoforms were cloned into pQE80 expression vector (QIAGEN) and transformed in 
DH5α cells.
25 ml of 2YT medium and the appropriate antibiotic (here: ampicillin) were inoculated with 
one colony for over night (oN) uncubation at 37 ºC. 20 ml of the oN culture were used to 
inoculate a one liter 2YT culture, growth at 37 ºC was monitored and stopped at a OD600 = 
0.6-0.8. Isopropylthio-β-D-galactoside (IPTG) was used in a concentration of 0.3 mM  for 
induction. After induction for 2 h at 37 ºC, 10 ml of 100 mM PMSF were added and the 
culture was transferred on ice for 15 min. Bacterial cells were collected in a low speed spin 
(3000 rpm, 10 min, 4°C, Sorvall RC5C, GS3 rotor), washed and again collected at 5500 rpm, 
15 min at  4 ºC using a Heraeus Megafuge 1.0. The resulting pellet was resuspended in 30 mL 
of the appropriate breaking buffer (Tris buffer + Roche Complete® Protease Inhibitor + 
EDTA) and sonified (2x2 min full power, 30% DutyCycle), or frozen in liquid nitrogen and 
stored at -80 ºC. Whole cell lysate was cleared from cell trash by low speed spinning (10 min 
at 2,000x g). To eliminate insoluble proteins and lipids, the supernatant was ultra centrifuged 
for 1 h at 100,000x g. Protein concentration was determined and Coomassie stained SDS 
PAGE gel electrophoresis was used to verify that the protein is not degraded.
3.2.2.1.2 Expression of GST tagged 14-3-3 Bmh1 and Bmh2 C-termini
14-3-3 Bmh1-/Bmh2-C termini were cloned into pGEX6PI expression vector and transformed 
in BL21 DE Star pRosetta cells.
20 ml of the oN culture (2YT medium +  ampicillin and chloramphenicol) were used to 
inoculate a one liter 2YT culture, growth at 37 ºC was monitored and stopped at a OD600 = 
0.6-0.8. Isopropylthio-β-D-galactoside (IPTG) in a concentration of 0.2 mM and 1 ml of 
benzylalcohol (induces chaperon expression, see de Marco et al., 2005) were used for 
induction. After 2 h at 37 ºC, 10 ml of 100 mM  PMSF were added and the culture was 
transferred on ice for 10 min. Bacterial cells were collected in a low speed spin (10 min, 
2,000x g at 4 ºC), resuspended in breaking buffer (20 mM HEPES, pH 6,8, 2% glycerol,
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150 mM KAc, 5 mM Mg(Ac)2, 1 mM  EDTA, 1 mM  DTT, 1 mM  PMSF, 1x Roche 
Complete® Protease Inhibitor + EDTA) and sonified. Whole cell lysate was processed further 
as described in 3.2.2.1.1.
3.2.2.1.3 Expression of His tagged Ndk1 protein
6xHis-tagged Ndk1 was cloned into pET21b expression vector (Pain lab) and transformed 
into BL21 DE Star pRosetta cells.
Culture was grown and processed as described in 3.2.2.1.1.
Sonication was performed in 1x LEW buffer from Protino Ni-NTA 2000 kit (Macherey-
Nagel).
3.2.2.1.4 Expression of GST tagged Sar1 protein
GST tagged Sar1 was cloned into pGEX-3x expression vector (A. Spang lab) and transformed 
in DH5α cells.
Culture was grown and processed as described in 3.2.2.1.1, except for the induction time, 
which was increased to 4 h with an IPTG concentration of 1 mM. The collected pellet was 
washed in TBS buffer (50 mM  Tris, pH 7.4, 150 mm NaCl) and sonified in TBS buffer + 1% 
Triton X-100.
3.2.2.2 Protein purification and immobilization
3.2.2.2.1 Purification of of untagged 14-3-3 proteins
The last 36 amino acids of the distal C-terminus of the KATP channel subunit Kir6.2 
(ccKir6.2) were fused to a mutated version of the GCN4 leucine zipper, pLI (see Harbury et 
al., 1993) and the affinity tag protein A (see Yuan et al., 2003). 5 ml of Sepharose 6 Fastflow 
beads (Amersham Biosciences) were diluted and sequentially  washed with binding buffer (50 
mM Tris-HCl, 50 mM  NaCl, 5 mM  magnesium acetate, pH 7.5). 600 µl of purified tetrameric 
Kir6.2 (Yuan et al., 2003) were incubated with the beads for 3 h at 4 ºC. Unbound protein was 
removed by washing with binding buffer. Beads with immobilized ccKir6.2 were transferred 
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to liquid chromatography columns (Sigma-Aldrich) and incubated with bacterial cell lysate 
with over expressed 14-3-3 isoform (see 3.2.2.1.1). 20 ml of binding buffer were used for 
washing. Fractions of 1 ml of purified, untagged 14-3-3 protein were collected by eluting with 
high salt buffer (0.5 M MgCl2, 50 mM Tris-HCl, pH 7.5). Protein concentration was 
determined and Coomassie stained SDS PAGE gel electrophoresis was used to verify that the 
protein is not degraded. Purified 14-3-3 protein solutions were dialyzed over night in the 
appropriate buffer.
3.2.2.2.2 Immobilization of GST tagged 14-3-3 Bmh1 and Bmh2 C-termini
GSH-agarose (Sigma) was incubated with MiliQ H2O over night at 4 ºC, washed twice with 
breaking buffer (see 3.2.2.1.2) and moved to a liquid chromatography column (Sigma-
Aldrich). The ultra-centrifuged supernatant from 3.2.2.1.2 was added. Increased amounts of 
bound GST-tagged protein could be achieved by repeated loading of GST-protein solution. 
Immobilized GST-tagged Bmh1-/Bmh2 C-terminus was used for interaction studies with 
Ndk1 protein and for pull-down experiments.
Increasing concentrations of MgCl2 in elution buffer (20 mM HEPES, pH 9.5, 10 mM GSH, 
5% glycerol, 150 mM KAc, 5 mM Mg(Ac)2, 1 mM EDTA, 1 mM DTT) were used for 
collecting 1 ml fractions.
3.2.2.2.3 Purification of His tagged Ndk1 protein
The supernatant from 3.2.2.1.3 was processed following the instructions of the Protino Ni-
NTA 2000 kit (Macherey-Nagel).
Protein concentration was determined and Coomassie stained SDS PAGE gel electrophoresis 
was used to verify that the protein is not degraded. Purified Ndk1 protein was dialyzed over 
night in the appropriate buffer.
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3.2.2.2.4 Purification of GST tagged Sar1 protein
Purification of GST tagged Sar1 protein occurred according to protocol from the Spang lab.
GSH-agarose (Sigma) was incubated with MiliQ H2O over night at 4 ºC, washed twice with 
TBST buffer (TBS buffer + 0.1% Tween 20) and the ultra-centrifuged supernatant from .
2.2.1.4 was added for 1 h at 4 ºC. Agarose was washed three time in TBST buffer, once in 
TBS buffer (see 3.2.2.1.4) and finally in TCN buffer (25 mM Tris, pH 8, 1 mM CaCl2, 100 
mM NaCl), resuspended in 5 ml TCN buffer and transferred to a liquid chromatography 
column (Sigma-Aldrich). 10 units of Factor Xa solution (Amersham) were added and the 
solution was incubated for 4 h at 25 ºC with occasional mixing. 5 ml (pool 1) were collected 
after uncapping the column. These fractions contain cleaved, untagged Sar1 protein in TCN 
buffer. 5 ml of B88 buffer (20 mM HEPES, pH 6.8, 150 mM KOAc, 250 mM sorbitol, 5 mM 
Mg(OAc)2) were added three times and the elutions were saved as pools 2-5. Protein 
concentrations of pools 1-5 were determined and pools containing highest protein 
concentrations were chosen. PMSF was added to a final concentration of 2 mM to pools 
containing Sar1. Protein solutions were cleared by ultra centrifugation (10 min at 50,000x g) 
and supernatants were aliquoted, frozen in liquid nitrogen and stored at -80 ºC.
3.2.2.3 Determination of protein concentration
Determination of protein concentration occurred as described by Bradford (1976). The change 
in absorbtion of the Coomassie-G-250 reagent is monitored at a wavelength of 595 nM using 
a spectrophotometer. Protein concentrations can be calculated by using the information from a 
standard curve (derived from defined concentrations of bovine serum albumin). 
Determination was repeated at least once to confirm the measured concentration.
3.2.2.4 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE (Tris-glycine SDS-polyacrylamide gel electrophoresis) is based on the binding of 
the anionic detergent SDS to proteins in a in a mass ratio of 1.4 g SDS :1 g protein. By doing 
so, SDS confers a negative charge to the polypeptide in proportion to its length. Therefore, 
protein migration in a gel matrix is determined not by intrinsic electrical charge of the 
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polypeptide, but  by molecular weight. SDS loading buffer was prepared with denaturizing 
reagents 2-Mercaptoethanol and DTT. The Hoefer Mighty  Small Gel System was used for 
separation of proteins. 
SDS PAGE resolving gels in a range of 8-13.5% were prepared as follows (20 ml total 
volume = 4 gels):
Solution components 8% gel 10% gel 13.5% gel
H20 9.3 ml 7.9 ml 5.6 ml
30% acrylamide  mix 5.3 ml 6.7 ml 9.0 ml
1.5 M tris (pH 8.8) 5.0 ml 5.0 ml 5.0 ml
10% SDS 0.2 ml 0.2 ml 0.2 ml
10% ammonium persulfate 0.2 ml 0.2 ml 0.2 ml
TEMED 0.012 ml 0.008 ml 0.008 ml
The stacking gel was prepared as follows (15 ml total volume = 4 gels):
Solution components Stacking gel
H20 10.2 ml
30% acrylamide  mix 2.6 ml
1.0 M tris (pH 6.8) 1.0 ml
10% SDS 0.15 ml
10% ammonium persulfate 0.15 ml
TEMED 0.015 ml
Proteins were separated by electrophoresis in a 1x Tris-glycine electrophoresis buffer using a
PowerPac 300 power supply (Bio-Rad) at 15-30 mA for approx. 30 min.
The PageRuler Prestained Protein Ladder (Fermentas) has been used as protein marker.
3.2.2.5 Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
A 5-18% Blue Native Polyacrylamide gradient gel was used to separate proteins in their 
native state. 
The gradient gel was poured by combining a 5% and a 18% separation gel mix in a gradient 
mixer using the following recipe:
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Solution components 4% stacking gel 5% separation gel 18% separation gel
H20 3.5 ml 5.0 ml 2.25 ml
AB (49.5%T, 3%C) 0.5 ml 0.9 ml 2.75 ml
3x gel buffer 2.0 ml 3.0 ml 2.5 ml
glycerol - - 1.5 g
10% ammonium persulfate 0.05 ml 0.05 ml 0.025 ml
TEMED 0.005 ml 0.005 ml 0.0025 ml
Samples were treated with 5x loading buffer (5% Coomassie, 50 mM BisTris, 750 mM ε-
aminocaproic acid, 50% glycerol, pH 7.0). The gel was run at 4 ºC with 300 V / 15 mA. After 
3 h the Coomassie containing cathode buffer was exchanged for a colorless cathode running 
buffer.
BSA and ferritin were used as protein markers.
3.2.2.6 Coomassie staining
SDS PAGE gels were incubated for 15 min in a fixation solution (40% ethanol, 10% glacial 
acetic acid in MiliQ H2O) and than stained in Coomassie Brillant Blue containing solution for 
30 min. The gel was washed and thereby destained in a destaining solution (20% ethanol, 
10% glacial acetic acid in MiliQ H2O). Additional destaining was achieved by incubating the 
gel in MiliQ H20 over night.
3.2.2.7 Western blot detection
Proteins were separated by SDS PAGE. The separation gel was carefully  removed and 
incubated in 1x transfer buffer for 20 min with gently  shaking. For wet blotting the Hybond-P 
PVDF transfer membrane (Amersham) was incubated for 10 min in methanol. For semi-dry 
blotting the Hybound ECL nitrocellulose membrane (Amersham) was incubated in transfer 
buffer for 10 min. Proteins were transferred by semi-dry blotting, using a semi-dry  transfer 
apparatus (Trans-Blot SD Cell, Bio-Rad) or by wet blotting using a Trans-Blot Cell (BioRad) 
according to the instructions given in the user manual. Successful transfer was verified by 
Ponceau staining and the dye was removed by extensive washes with MiliQ H2O. The stained 
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membrane was incubated in blocking solution (5% (w/v) milk powder in 1x TBS and 0.01% 
Nonidet-P40) for at least 1 h at room temperature or over night at 4 ºC to minimize unspecific 
signals. Primary antibodies were diluted in an optimist concentration in blocking solution and 
incubated with the membrane for 1 h. After this, membrane was washed (4 times, 5 min each) 
with blocking solution and incubated with secondary antibody in blocking solution (1:7,000) 
for HRP detection (30 min at room temperature (RT)) or in Alexa Fluor secondary antibodies 
(1:5,000,  in 1x PBS, 0.1% Tween-20, 0.01% SDS, 3% milk powder) for detection with the 
Licor Odyssey system (1 h on darkness at  4 ºC). Membranes for HRP detection were washed 
(4 times, 5 min each in blocking solution) at RT,  membranes for Licor Odyssey detection 
were washed (4 times, 5 min each in 1x PBS, 0.1% Tween-20) in darkness. Washing was 
completed with a final washing step with 1x TBS and 0.01% Nonidet-P40 for HRP detection 
and 1x PBS, 5 min wash for Licor Odyssey detection.
HRP detection:
Membranes were rinsed in MiliQ H2O once and incubated with prepared 1.5 ml ECL reagent 
(Amersham) for 2 min. The ECL-film was developed in the dark room. Exposure time varied 
from 2 sec to overnight depending on the requirement.
Licor Odyssey detection:
Membranes were transferred quickly (to prevent exposure to light) onto a Licor Odyssey 
scanning unit. A prescan was performed to determine optimal scanning intensity and to define 
the scanning region. Final scans were done with a resolution of 84 µm and medium quality 
settings. Membranes were always kept  wet during the scanning procedure. Licor Odyssey 
software was used to obtain quantitative information of single protein bands.
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3.2.3 Working with yeast
3.2.3.1 Preparation of yeast total cell extract
An over night yeast culture was grown to early- to mid-log phase and collected by 
centrifugation (3 min, 3000 rpm with table top centrifuge). The pellet was resuspended in 200 
µl of 0.1 M  NaOH, vortexed and incubated for 10 min at  RT. During incubation, 10 µl of the 
cell suspension were diluted in 990 µl of H2O and OD600 was determined. The resulting value 
defines the amount of SDS loading buffer, that was added to the pellet  after the following spin 
(1 min, 12,500 rpm with table top centrifuge): 1 OD unit = 1,000 µl of added SDS loading 
buffer. The resuspended pellet in SDS loading buffer was heated up to 65 ºC for 10 min.
3.2.3.2 Preparation of yeast cytosol
1-3 l of yeast culture were grown to to early- to mid-log phase and collected by centrifugation 
(5 min, 3,000x g). Cells were washed once in MiliQ H2O and the pellet was resuspended in 2 
ml of appropriate buffer. The dense cell suspension was slowly dropped into liquid nitrogen. 
Cells were lysed using mortar and pestle until only a fine powder was left. The resulting cell 
powder was then thawed in an ice-water bath, diluted with ice cold buffer (up to 30 ml) and 
cleared in a first  spin (10 min, 10,000x g). The supernatant was then ultracentrifuged (1 h, 
100,000x g). Clean cytosol was removed, avoiding the lipid layer on top  and pellet on the 
bottom of the tube. Protein concentration was determined and small aliquots were frozen in 
liquid nitrogen and stored at -80 ºC.
3.2.3.3 Preparation of ER enriched membranes from yeast cells
ER enriched membranes were prepared adopting the protocol as described by Wuestehube 
and Schekman.
Yeast cultures were grown to an OD600=2 and harvested by centrifugation (7 min, 2,000x g). 
The pellet was resuspended in 10 ml Buffer A (see below for detailed description) per liter of 
yeast culture and incubated for 10 min at RT with gentle agitation. Cells were collected (7 
min, 2,000x g) and resuspended in Resuspension buffer (see below for detailed description) 
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and 40 µl of zymolyase (dilution: 0.03 g powder /200 µl MiliQ H2O) per liter of initial yeast 
culture. Cell suspension was incubated for up to 1.5 h at 30 ºC and digestion of yeast cell wall 
was monitored until OD600 value dropped to less than 5% of the initial value. The resulting 
spheroplasts were washed by collection through a sucrose cushion (see below for detailed 
description) at 5,500x g, 20 min at 4 ºC. Alternatively, spheroplasts can be washed twice in 
Buffer B (see below for detailed description) and collected at 1,000x g, 5 min at 4 ºC. In both 
cases the resulting pellet was slowly frozen at -80 ºC and stored on -80 ºC until further 
processing (usually the next day). All processing steps were performed at 4 ºC. Thawing of 
the frozen spheroplast pellet occurred in a water-ice bath. After this, cold Lysis buffer (see 
detailed description below) was added in a ratio pellet to buffer of 3:1. The pellet was 
resuspended by vortexing and transferred to a douncer. Cells were homogenized slowly on ice 
using a douncer (douncing: 30 times), centrifuged (10 min, 3,000x g), again resuspended in 
Lysis buffer in the same 3:1 ratio and douncing and centrifugation were repeated. The 
resulting supernatant was transferred into ultracentrifugation tubes and membranes were 
collected by spinning for 10 min at 27,000x g. The supernatant was removed carefully, 
discarded and the pellet was resuspended in 3 ml Lysis buffer per 1 l of initial yeast  culture. A 
sucrose density  gradient was prepared from 1.5 M and 1.2 M sucrose (in HEPES buffer) 
solutions. The membrane suspension was then loaded carefully onto the 1.2 M sucrose layer 
and ER enriched membranes (microsomes) were collected from the 1.5 M/1.2 M interphase 
after ultracentrifugation (1 h, 100,000x g). Microsomes were washed twice in B88 buffer (see 
below for detailed description) and collected by centrifugation (10 min, 27,000x g). Finally, 
microsomes were resuspended in B88 buffer by  adding 300 µl buffer per 1 liter of initial yeast 
culture, aliquoted in 16 µl samples, frozen in liquid nitrogen and stored at -80 ºC. Protein 
concentration was determined as described in 3.2.2.3.
Buffer A:
Reagent Volume: 1 l
100 mM Tris-HCl, pH 9.4 12.1 g
10 mM DTT 10 ml
MiliQ H2O ad to 1 l
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Resuspension buffer:
Reagent Volume: 250 ml
0.7 M sorbitol 31.88 g
1.5% (w/v) bacto peptone 3.75 g
0.75% (w/v) yeast extract 1.88 g
0.5% (w/v) glucose 3.1 ml of 40% Glc solution
10 mM Tris-HCl, pH 7.4 2.5 ml of 1 M Tris-HCl, pH 7.4
MiliQ H2O ad to 250 ml
Sucrose cushion:
Reagent Volume: 500 ml
0.8 M sucrose 137 g
1.5% (w/v) Ficoll-400 7.5 g
20 mM HEPES, pH 7.4 10ml of 1 M HEPES, pH 7.4
MiliQ H2O ad to 500 ml
Wash buffer B:
Reagent Volume: 1 l
0.7 M sorbitol 127.5 g
1.5% (w/v) Ficoll-400 7.5 g
20 mM HEPES, pH 7.4 20 ml of 1 M HEPES, pH 7.4
MiliQ H2O ad to 1 l
Lysis buffer:
Reagent Volume: 500 ml
0.1 M sorbitol 9.1 g
20 mM HEPES, pH 7.4 10ml of 1 M HEPES, pH 7.4
50 mM KAc 2.45 g
2 mM EDTA 2.0 ml of 0.5 M EDTA solution
1 mM DTT 500 µl of 1 M DTT stock solution
1 mM PMSF 0.085 g
Complete® Protease Inhibitor (Roche) add 1 tablet /50 ml buffer before use 
(if requested)
MiliQ H2O ad to 500 ml
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Sucrose density step gradient:
Reagent Volume: 100 ml
1.5 M sucrose 53.3 g 1.5 M sucrose solution
1.2 M sucrose 41.1 g 1.2 M sucrose solution
20 mM HEPES, pH 7.4 2 ml of 1 M HEPES, pH 7.4
MiliQ H2O ad to 100 ml
Reaction buffer B88:
Reagent Volume: 250 ml
20 mM HEPES, pH 6.8 5 ml of 1 M HEPES, pH 6.8
150 mM KAc 3.68 g
5 mM MgAc 0.40 g
250 mM sorbitol 11.4 g
MiliQ H2O ad to 250 ml
3.2.3.4 Preparation of Golgi enriched membranes from yeast cells
Golgi membranes were enriched using a protocol by the Spang lab.
3 l of yeast culture was grown to early- to mid-log phase and collected by centrifugation (5 
min, 3,000x g). The pellet was washed once in MiliQ H20 and resuspended in 2 ml B88 
buffer. The dense cell suspension was slowly  dropped into liquid nitrogen. Cells were lysed 
using mortar and pestle. The resulting cell powder was thawn in an ice-water bath and 
afterwards diluted with up  to 30 ml of B88 buffer, 1 mM DTT and 1 mM PMSF. Supernatant 
from the spin (5 min, 5,000x g) was collected and ER membranes were removed by  two 
additional spins (15 min, 15,000 rpm SW40 rotor). The ER free supernatant was than loaded 
on a 60% sucrose cushion and centrifuged (30 min, 100,000x g). Membranes, which 
sedimented on the cushion were collected, diluted to the volume prior to ultracentrifugation, 
loaded on the 60% sucrose cushion and the ultracentrifugation step was repeated. Finally, 
Golgi enriched membranes were collected from the interphase and 200 µl aliquots were 
frozen in liquid nitrogen and stored at -80 ºC after determination of the protein concentration.
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3.2.3.5 Yeast transformation
Yeast cells were transformed using the lithium acetate method described by Ausubel et al., 
1997. One yeast colony was picked and grown in appropiate medium (YPAD or selective 
medium) at the appropriate temperature (usually 30 ºC, 25 ºC for temperature sensitive 
starins). Yeast cells were then collected by low speed spin, washed in MiliQ H2O and 
resuspended in 200 µl lithium acetate buffer (100 mM lithium acetate, pH 7.5, 50 mM 
TrisHCl, pH 7.5, 1 mM  EDTA). 1-3 µg plasmid DNA, 18 µl boiled carrier DNA (10 mg/ml in 
TrisHCl, pH 8.0, 1 mM  EDTA) and 1.2 ml polyethylenglycol (100 mM  lithium acetate, pH 
7.5, 50 mM TrisHCl, pH 7.5, 1 mM EDTA, 40% (w/v) polyethylenglycol 4000) were added 
and mixed by vortexing. Incubation occurred at 42 ºC and at RT for temperature sensitive 
strains. After this, yeast cells were collected by  centrifugation (5 min, 2,000x g), resuspended 
in sterile MiliQ H2O and plated onto appropriate agar plates.
3.2.3.6 Deletion of yeast genes
Deletion of 14-3-3 BMH1 and BMH2 genes in the background of a ∆ndk1 strain was realized 
by homologues recombination. Therefore a natMX4 cassette (containing the resistance gene 
for the antibiotic nourseothricin) was amplified from pAG25 vector, by  using long primers, 
which included flanking regions of either BMH1 or BMH2 genes. PCR products (10 µl, 30 µl 
and 50 µl) were transformed into the ∆ndk1 strain and cells were streaked out on YPAD plates 
containing 100 µg/ml nourseothricin. After few days at 30 ºC, colonies were picked and 
incubated at 30 ºC in nourseothricin containing liquid medium. The new knockout was verfied 
by PCR and Western blotting.
3.2.3.7 Creation of a C-terminally 6xHA tagged Ndk1 fusion protein
To genomically tag the Ndk1 protein by 6xHA, a PCR-based tagging method was applied. 
Using the following primer pair, that include the C-terminal region of Ndk1 and the 3’ region 
following the NDK1 gene, the 6HA sequence and a HIS3 marker sequence were amplified by 
PCR and inserted into wildtype, ∆bmh1 and ∆bmh2 yeast strains by homologues 
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recombination. The insertion of a HIS3 marker sequence allowed screening for correctly 
inserted 6xHA-tagged NDK1 on yeast plates lacking the amino acid Histidine.
(1) NDK1_Ctag_For: GAG-TTA-GTT-GAT-TGG-GAA-TCT-AAT-CAA-GCT-AAG-
TGG-ATT-TAT-GAA-CGT-ACG-CTG-CAG-GTC-GAC
(2) NDK1_Ctag_Rev: AGA-AAA-AAA-AGG-CGC-TCA-TAT-GTA-CCC-TCC-CAT-
GCC-ATA-AGT-TAT-ATC-GAT-GAA-TTC-GAG-CTC-G
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3.2.4 Microscopy techniques
3.2.4.1 Life cell imaging
Live cell imaging was done by  fluorescence microscopy  and performed at RT in SC medium 
employing a DeltaVision restoration microscope equipped with a 100×/0.35-1.5 Uplan Apo 
objective and a Sedat quadruple filter set (Chroma 86000v2). Images were collected with a 
Coolsnap HQ camera (Photometrics); the Z optical spacing was 0.3 µm. Raw images were 
deconvolved using the conservative additive algorithm of Softworx software.
Localization of proteins, coupled to fluorescence markers (YFP or GFP) was monitored.
3.2.4.2 Immunofluorescence
25 ml of yeast culture was grown to early logarithmic phase and 2.5 ml of commercial 37% 
formaldehyde solution (filtered through 0.45 µm filter) was added for 45 min. Cell were 
collected at 2,000x g, 5 min and washed with fresh 4% formaldehyde fixation solution (for 50 
ml: 2 g paraformaldehyde, heat, add 350 µl of 6N NaOH until solution clears, add 0.68 g 
KH2PO4 and 50 µl 1 M MgCl2 (pH 6.5), filter through 45 µm filter) twice and finally 
resuspended and incubated in 4% formaldehyde fixation solution for 12-16 h with gentle 
shaking. Yeast cells were then harvested and washed with 200 mM Tris, pH 8, 20 mM  EDTA, 
1% beta-mercaptoethanol buffer (filtered) for 10 min. After collecting the cells by a low-
speed spin (2,000x g, 5 min) cells were resuspended in spheroblasting buffer (1.2 M  sorbitol, 
50 mM potassium phosphate, pH 7.3, 1 mM  MgCl2, filtered) and zymolyase was added to a 
concentration of 0.15 mg/ml for 45 min at 37 ºC. Spheroblasts were collected at 2,000g, 5 min 
and washed twice in 1 ml of 1.2 M sorbitol, resuspended in 1.2 M sorbitol and 15-25 µl of 
spheroblasts were applied per well (Teflon-masked multiwell slides, pre-treated with poly-L-
lysine solution have been used). Incubation time was 15 min, followed by two washes with 
PBS-BSA solution (1x PBS with 10 mg/ml BSA, filtered) and blocking with PBS-BSA for 30 
min. Primary  antibody diluted in PBS-BSA was applied over night. Cells were then washed 4 
times with PBS-BSA before incubation with secondary antibody (fluorochrome-coupled) for 
30 min at 37 ºC. Cells were washed extensively with PBS-BSA and PBS before cover slips 
were sealed. 
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The same microscopy setup as described in 3.2.4.1 has been used.
3.2.5 Surface plasmon resonance
Surface plasmon resonance experiments were performed on a BIAcore-3000 (Biacore, 
Uppsala, Sweden). Immobilization of a protein A-cc-LRKR fusion protein (with the 
tetramerforming coiled-coil domain pLI denoted –cc-) to the CM5 Chip  (Biacore) was 
performed using the N-hydroxysuccinimide / N-ethyl-N'-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (NHS/EDC) method. All steps were performed as described in 
the user manual. Finally, 650 RU of the tetrameric fusion protein were immobilized. Purified 
Bmh1 and Bmh2 were dialyzed overnight against 10 mM HEPES, 150 mM NaCl, 50 µM 
EDTA, 0.005 % (w/v) Tween20, pH 7.4. The flow cells were equilibrated with exactly the 
same buffer at RT. Measurements took place at a flow-rate of 20 µl/min at 25° C. The 
reference flow-cell was exposed to the same coupling procedure in the absence of any fusion 
protein and served as reference for background binding. Concentrations in the range of 11.7 
nM to 750 nM of the purified protein have been used. The chip  was regenerated in a 1.5 M 
MgCl2 solution and washed extensively with the equilibration buffer (see above). The binding 
parameters were analyzed with the BIAevaluate 3.0 software (Biacore) using the 1:1 binding 
(Langmuir) fitting protocol under the assumption that 14-3-3 proteins were present in the 
dimeric form. Consistent with this assumption both purified 14-3-3 proteins migrated as 
dimers when subjected to blue native gel electrophoresis.
3.2.6 In vitro COPII budding assay
ER enriched membranes (microsomes) of yeast strains were purified as described in 3.2.2.3. 
Microsomes were adjusted to equal total protein concentrations by dilution in B88 buffer 
(concentration used: 10 µg/µl).  A typical COPII budding assay was setup as follows:
Microsomes Cytosol Sar1 GTPγS / GDP ATP reg. system B88
7 µl 1 µl - - - 42 µl
7 µl 1 µl 1 µl 10 µl 10 µl 21 µl
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Yeast cytosol (20 µg of total protein per reaction), purified Sar1 (100 ng per reaction), GTPγS 
(2 mM end concentration) and ATP regeneration system (Baker et al, 1988) were prepared in 
B88 buffer. Only fresh reagents were used. 
Microsomes were incubated for 30 min at 30°C. The budding reaction was stopped by 
transferring microsomes to ice for 5 min and formed vesicles were separated by low speed 
centrifugation (5 min at 13,000 rpm at 4°C). After this, vesicles were collected by  a high-
speed spin (30 min at 35,000 rpm, TLA55 rotor at  4°C). The pellet was resuspended in 30 µl 
of SDS loading buffer and protein content on sedimented vesicles was analysed by SDS-
PAGE and Western blotting.
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4. Results
4.1 Purification of untagged 14-3-3 proteins and antibody 
production
To investigate mechanistic details of the isoform specific role of 14-3-3 proteins in the 
forward transport of multimeric membrane proteins biochemical methods need to be applied. 
Quantitative studies of protein-protein interactions require substantial amounts of purified 
proteins. Biochemical studies, as well as microscopy studies rely  on functional antibodies. For 
this reason, the first aim of this work was to establish a method to purify 14-3-3 proteins, 
followed by the intention to produce an antibody, that specifically  recognises yeast 14-3-3 
isoforms Bmh1 and Bmh2. 
The previously described binding of 14-3-3 proteins to Arg based motifs raised the idea to use 
this protein-protein interaction for purification of untagged 14-3-3 proteins instead of affinity 
tags fused to the protein (see Yuan et al., 2003). Therefore, a construct  created by Yuan et al., 
where the last 36 amino acids of the distal C-terminus 
of the KATP channel subunit Kir6.2 (ccKir6.2) were 
fused to a mutated tetramerizing version of the 
GCN4 leucine zipper, pLI (see Harbury et al., 1993) 
and the affinity tag protein A (see Yuan et al., 2003) 
was immobilised on IgG sepharose. 14-3-3 proteins 
were over expressed in bacterial cells and the cleared 
cell lysate was incubated with immobilised ccKir6.2 
(see cartoon in Fig. 10). Presentation of the Arg 
based motif in the Kir6.2 tail in a multimeric fashion 
strongly increases the binding affinity  to 14-3-3 (see 
Yuan et al., 2003). High salt buffer abolishes the 
protein-protein interaction and was used for elution. 
High amounts of untagged 14-3-3 isoforms could be 
obtained (see Fig. 11 A and B as an example for 
14-3-3 Bmh1 and Bmh2). All seven mammalian 
isoforms as well as both yeast isoforms Bmh1 and 
Bmh2 could be purified using this strategy.
Figure 10: Cartoon of the purification of 
untagged 14-3-3 proteins from bacterial 
lysates.
The last 36 amino acids of  the distal C-
terminus of  the KATP channel subunit Kir6.2 
(ccKir6.2) were fused to a mutated version of 
the GCN4 leucine zipper, pLI (see Harbury et 
al.,  1993) and the affinity  tag protein A  (see 
Yuan et al.,  2003). The tetrameric presentation 
of the Arg based motif present in Kir6.2 
resulted in a strongly enhanced binding to 
14-3-3 proteins and enabled purification of 
untagged 14-3-3 isoforms.
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Figure 11: Antibody production employing purified 14-3-3 Bmh1 and Bmh2 proteins.
(A) Typical Coomassie stained SDS-PAGE gel of purified yeast 14-3-3 Bmh1. 
1L of bacterial culture was grown to an OD600=0.8 and IPTG induced for 2 h. The bacterial lysate was 
ultracentrifuged and cleared using a two step ammonium phosphate precipitation. The resulting pellet was 
resuspended in binding buffer and loaded on the saturated IgG sepharose column containing ccKir6.2.
Elution was performed using high salt (1.5 M MgCl2). Fractions of  1 ml were collected and 10 µl of each fraction 
were loaded in each lane. The average protein concentration was approx. 1 µg/µl.
Asteriks mark fractions used for antibody raising.
(B) Typical Coomassie stained SDS-PAGE gel of purified yeast 14-3-3 Bmh2 (see (A) for details).
(C) Increasing amounts of purified and pooled 14-3-3 Bmh1 and Bmh2 proteins were loaded on a 10% SDS gel 
and Coomassie stained.
 2.5 µl to 20 µl were taken from protein solution that was used for raising an antibody directed against Bmh1/
Bmh2. Total volume of Bmh1/Bmh2 protein solution was 11 ml with a protein concentration of approx. 1 µg/µl.
(D) Test of serum 3383: Both yeast 14-3-3 isoforms could be detected by Western blot analysis of a purified 
protein mix using sample bleed 4 and 5. A serum dilution of 1:500 was used. 170 ng of Bmh1/Bmh2 protein mix 
and 5 µl cytosol from single and double knockout strains (150 µg total protein) were loaded in each lane.
(E) Test of serum 3384: Both yeast 14-3-3 isoforms could be detected by Western blot analysis of yeast cytosol by 
using sample bleed 4 and 5. A serum dilution of 1:500 was used. 170 ng of Bmh1/Bmh2 protein mix and 5 µl 
cytosol from single and double knockout strains (150 µg total protein) were loaded in each lane.
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For the purpose of producing an antibody that recognises yeast 14-3-3 isoforms, purified 
Bmh1 and Bmh2 were pooled to a total volume of 11 ml with a concentration of 
approximately 1 µg/µl (see Fig. 11 C). The protein solution was sent out to EUROGENTEC 
(Belgium) to run an immunisation program in rabbits. The resulting anti-Bmh antiserum was 
tested in Western blot detection as shown in figure 11 D and E. Sample bleeds 4 and 5 of 
rabbits 3383 and 3384 were used. Two bands could be detected for the Bmh1/Bmh2 protein 
mixture. Only the upper Bmh2 band, or the lower Bmh1 band was detected in the according 
∆bmh1 or ∆bmh2 single knockouts. No band was detected in the double-deletion strain 
∆bmh1∆bmh2. Hence the antiserum specifically  labelled yeast 14-3-3 proteins Bmh1 and 
Bmh2. The same antiserum was also successfully  used in immunofluorescence (see Fig. 21, 
chapter 4.5).
4.2 Abundance of 14-3-3 Bmh1 and Bmh2 as potential 
explanation for isoform specificity
As shown in Figure 3 only Bmh1 but not Bmh2 is able to promote forward transport of the 
tetrameric ccPmp2-reporter protein. Previously, the hypothesis of 14-3-3 proteins masking the 
COPI retrieval Arg-based motif has been formulated (Yuan et al., 2003). Based on this idea, 
several hypothesis were tested to explain the differential effect. One of them being the idea, 
that differences in copy  number of the 14-3-3 isoforms create a situation in vivo where only 
one isoform is able to fulfil a productive function because it is present, whereas the other 
isoform is simply not abundant enough to provide the same degree of masking. Protein copy 
numbers have been previously  suggested for yeast  14-3-3 proteins based on quantitative 
Western blotting of fusion proteins (Ghaemmaghami et al., 2003): 158,000 molecules per cell 
for Bmh1 and 47,600 molecules per cell for Bmh2. Since the number of proteins per cell for 
Bmh1 is more than three times higher than for Bmh2, the positive role of Bmh1 in ccPmp2 
forward transport could be explained by  differences in abundance. The loss of Bmh1 in a 
∆bmh1 strain could be more drastic than the loss of Bmh2 in a ∆bmh2 strain.
To answer this question two methods have been tested to quantify 14-3-3 proteins in yeast.
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4.2.1 Quantification of Bmh1 and Bmh2 using FACS
Fluorescence-activated cell sorting (FACS) enables screening and sorting of cells expressing 
proteins tagged with fluorescence markers. A C-terminally GFP tagged version of either 
Bmh1 or Bmh2 was overexpressed in a yeast wildtype strain using a p416 vector. The idea 
was to calibrate GFP fluorescence as a reporter of 14-3-3 levels, with the goal of investigating 
genomically tagged variants in individual knockout strains. For that reason 30,000 cells 
overexpressing GFP tagged versions of either Bmh1 or Bmh2 were sorted and the median 
value was determined (see Fig. 12 A-E and 13 A-E). In parallel, 2 mio GFP positive cells 
were sorted and collected for each isoform and 14-3-3 protein levels were obtained using 
quantitative Western blot  analysis. Using precise amounts of the according purified, untagged 
14-3-3 isoform, a standard curve was created and used for calculation of the amount of 
overexpressed GFP tagged 14-3-3 protein (see Fig. 12 F and 13 F). 
Scanning for GFP positive cells resulted in median values for Bmh2-GFP that were twice as 
high as values for Bmh1-GFP, although protein amounts for the same number of scanned 
GFP positive cells were very similar (Bmh1: 6.5 ng/1 mio cells, Bmh2: 7.3 ng/1 mio cells). 
Conclusively, the amount of FACS scanned GFP did not correlate with expressed GFP tagged 
14-3-3 proteins. However, one has to mention critically, that the GFP protein amount was out 
of range in the quantitative Western blot analyses (see Fig. 12 F and 13 F), showing that 
protein amounts should only  be calculated while being in the range of the calibration curve. A 
disadvantage of the performed FACS measurements becomes clear when comparing the 
overexpressed Bmh2-GFP bands with the endogenously expressed Bmh2 (see Fig. 13 F). The 
amount of GFP tagged Bmh2 exceeded the endogenous Bmh2 amount by several times. 
Overexpression of 14-3-3 proteins however, leads to disorganisation of subcellular 
compartments (see Fig. 15 A). A controlled expression (by making use of the MET25 
promoter in p416) or genomically tagged 14-3-3 proteins in single knockout strains would be 
a way to eliminate that problem. Still, the disadvantage of having GFP tagged proteins 
remains. The tag could obscure important  parts of the 14-3-3 proteins and interfere with 
binding to other proteins. Therefore I decided to quantify  endogenous levels of Bmh1 and 
Bmh2 in single knockout strains by  quantitative Western blotting only. However, to obtain 
meaningful results I carefully calibrated the signal and quantified only bands well within the 
calibration curve (see next paragraph).
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Figure 12: Comparison of FACS and quantitative Western Blot analysis to determine 14-3-3 Bmh1 protein 
copy numbers per cell.
Determination of GFP intensities for cells overexpressing Bmh1-GFP using FACS.
(A) Graph showing whole cell population of cells overexpressing Bmh1-GFP. X-axis shows forward scatter, which 
correlated with cell size. Y-axis  shows side scatter with correlated with cell shape. Only cells of proper size and 
shape were selected.
(B) Graph showing selected cell population from (A) stained by PI to mark the nucleus of dead cells. X-axis shows 
cell size, Y-axis shows positive PI staining.
Only cells that were PI negative were selected.
(C) Graph showing selected cell population from (B). Cells  were detected for GFP fluorescence. X-axis shows cell 
size, Y-axis shows GFP fluorescence.
Only cells that were GFP positive were selected.
(D) Histogramm showing selected cell population from (C). Cells were detected for GFP fluorescence. X-axis 
shows GFP fluorescence, Y-axis shows number of cells.
Only cells that were GFP positive were selected.
(E) Table summarizing the results for scanning 30,000 cells overexpressing Bmh1-GFP. The median value for 
GFP positive cells that passed the selected gates (see A, B, C and D) was 732.
(F) 2 mio. cells overexpressing Bmh1-GFP were sorted and collected using the criteria as described in A, B, C 
and D. Yeast cells were lysed and whole cell lysate was loaded on a SDS-PAGE gel, blotted and detected with 
anti-Bmh2 antibody. A standard curve was created using precisely defined amounts of purified Bmh1 protein and 
measuring the integrated signal of the protein bands using ImageJ software. The amount of overexpressed 
Bmh1-GFP protein was calculated using the information from the standard curve.
A B C
D E
F
endogenous Bmh1
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Figure 13: Comparison of FACS and quantitative Western Blot analysis to determine 14-3-3 Bmh2 protein 
copy numbers per cell.
Determination of GFP intensities for cells overexpressing Bmh2-GFP using FACS.
(A) Graph showing whole cell population of cells overexpressing Bmh2-GFP. X-axis shows forward scatter, which 
correlated with cell size. Y-axis shows side scatter with correlated with cell shape. Only cells of proper size and 
shape were selected.
(B), (C) and (D): See description of Figure 12 for more details.
(E) Table summarizing the results  for scanning 30,000 cells overexpressing Bmh2-GFP. The median value for 
GFP positive cells that passed the selected gates (see A, B, C and D) was 1,324.
(F) 2 mio.  cells overexpressing Bmh2-GFP were sorted and collected using the criteria as described in A, B, C 
and D. Yeast cells were lysed and whole cell lysate was loaded on a SDS-PAGE gel, blotted and detected with 
anti-Bmh2 antibody. A standard curve was created using precisely defined amounts of purified Bmh2 protein and 
measuring the integrated signal of  the protein bands using ImageJ software. The amount of overexpressed 
Bmh2-GFP protein was calculated using the information from the standard curve.
endogenous Bmh2
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4.2.2 Quantification of endogenous 14-3-3 proteins
According to Ghaemmaghami and colleagues loss of Bmh1 in the ∆bmh1 strain would reduce 
total 14-3-3 levels by two-third. However, 14-3-3 proteins are essential and the cell may 
counter regulate by increased expression of the remaining isoform. 
To clarify to what extent the loss of the more abundant isoform Bmh1 reduces total amount of 
14-3-3s in the ∆bmh1 strain and whether the remaining Bmh2 was drastically  less abundant, 
106 yeast cells from either wildtype, ∆bmh1 or ∆bmh2 strains were collected by FACS and 
whole cell lysates were analysed by  Western blotting and detected with anti-Bmh2 antiserum 
(van Heusden et al., 1995). Using defined amounts of purified Bmh1 or Bmh2 a calibration 
curve was obtained and protein copies per cell could be calculated by analysing the integrated 
density  of the protein bands using image analysis software (see Fig. 14). Measurements 
resulted in 133,000 (±  16,000; SEM; n=4) copies per cell for Bmh1 and 58,000 (±  19,000; 
SEM; n=3) copies per cell for Bmh2 in a wildtype strain. Both numbers are very comparable 
to Ghaemmaghami et al. Interestingly, copy numbers for both isoforms were strongly 
upregulated in single knockout strains: 214,000 (± 22,000; SEM; n=4, upregulation of 27%) 
A Figure 14: Quantification of endogenous Bmh1 
and Bmh2 proteins in single knockout strains.
(A) Quantification of 14-3-3 Bmh1.
106 cells expressing only 14-3-3 Bmh1 but not 
Bmh2 were sorted and collected using the criteria 
as described in figure 3 (A) and (B). Yeast cells 
were lysed and whole cell lysate was loaded on a 
SDS-PAGE gel, blotted and detected with anti-
Bmh2 antibody (van Heusden et al.,  1995).  A 
standard curve was created using precisely defined 
amounts of either purified Bmh1 or Bmh2 protein 
and measuring the integrated signal of the protein 
bands using ImageJ software. The amount of 
expressed Bmh1 or Bmh2 protein was calculated 
using the information from the standard curve.
(B) Quantification of 14-3-3 Bmh2: Details as in (A).
B
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copies per cell for Bmh1 in the Δbmh2 strain and 93,000 (±1,900; SEM; n=2, upregulation of 
38%) copies per cell for Bmh2 in the Δbmh1 strain, suggesting a general functional 
compensation of one isoform for the other (see Table 3 A). 
Isoform specific effects of Bmh1 and Bmh2 have been reported in several studies (Gelperin et 
al., 1995; Roth et al., 1999; Demmel et al., 2008). However, it is unclear whether the 
demonstrated effects are due to a change in total 14-3-3 copy  numbers, or loss of 
heterodimers, or even increase of specific homodimers. My data allows the estimation of the 
respective dimer populations in the ∆bmh1 and ∆bmh2 single knockout strains as opposed to 
the wildtype (see Table 3 B). It is worth keeping in mind for the interpretation of further 
experiments, that Bmh2/Bmh2 homodimers represent a very rare species in wildtype cells 
(7% of all 14-3-3 dimers), but are more than four-fold abundant in a ∆bmh1 strain 
(upregulation 412% in comparison to wildtype). Despite the upregulation of Bmh2/Bmh2 
Table 3: Yeast 14-3-3 isoforms are upregulated in single knockout strains.
(A) Summary of yeast  14-3-3 protein copies per cell in a wildtype strain (EuWTa) and single 14-3-3 knockout 
strains.  See description of Figure 14 (A) for more detail. Numbers are derived from 5 (in EuWTa) and 4 (in 
∆bmh2) measurements for Bmh1 and 3 (in EuWTa and ∆bmh1) measurements for Bmh2. Standard error is given 
in brackets. The resulting difference in copy numbers per cell between wildtype and single knockout strains is 
given in percent.
A
B
(B) Calculation of total number of homo- and hetero-14-3-3 dimers in wildtype and single knockout strains. The 
number of Bmh2 homodimers increases by 412% compared to wildtype, whereas the number of Bmh1 
homodimers increases only by 80%.
Calculations were done according to the following equation (see Steinmeyer et  al.,  1994): NH1/H2 = nH1/H2/
k(1+a)k-1 , with N  being the total number of Bmh1 or Bmh2 homo dimers, n being the total number of Bmh1 or 
Bmh2 subunits, a the ratio of nH2/nH1 for Bmh1 homo dimers and nH1/nH2 for Bmh2 homo dimers and k the 
number of subunits (here two).
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homodimers there was still only ~37% of the total amount of 14-3-3 dimers present in a 
∆bmh1 strain in comparison to wildtype.
Still, the difference in protein copy numbers between Bmh1 and Bmh2 was two-fold. To 
address the question, if overexpression of Bmh2 will rescue the defect in forward transport of 
ccPmp2 in the ∆bmh1 strain, microscopy studies with highly overexpressed Bmh2 in the 
∆bmh1 background have been performed (see Fig. 15). Despite Bmh2 being present at a copy 
number of approximately 261,000 (±  9,600; SEM; n=8) proteins per cell, no forward transport 
of the multimeric reporter protein could be observed. In contrast, ccPmp2 strongly 
accumulated in the ER of the cell. Notably, the morphology of the ER was disturbed as a 
consequence of Bmh2 overexpression.
Figure 15: 14-3-3 Bmh2 overexpression does not  rescue  the defect in forward transport of the  ∆bmh1 
strain.
(A) Localization of the ccKir6.2 reporter in the ∆bmh1 MET25::BMH2 background.
Fluorescence life cell imaging using a GFP labeled tetrameric Pmp2 reporter protein (ccKir6.2).
The nucleus was marked using a Histone marker, perinuclear ER was highlighted with an arrow.
Despite the overexpression of the Bmh2 isoform the tetrameric ccKir6.2 reporter protein is not able to leave the 
ER efficiently.
(Microscopy performed by K. Michelsen)
(B) Quantification of 14-3-3 Bmh2 in the ∆bmh1 MET25::BMH2 background.
See text for corresponding statistics. For detailed description see Figure 14 (B).
A
B
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4.3 Dimerization of 14-3-3 proteins in vitro
A major feature of 14-3-3 proteins is their ability to dimerize via highly  conserved N-terminal 
regions (Rittinger et al., 1999) by interactions of their first four alpha helices αA-αD (Xiao et 
al., 1995, Liu et al., 1995). This allows 14-3-3 proteins to act  as scaffolding proteins or to 
recruit additional proteins (Mrowiec and Schwappach, 2006). In other words, some proposed 
14-3-3 mechanisms require dimerization. Since the possibilty to form heterodimers was 
shown for 14-3-3 isoforms (Jones et al., 1995), I asked if the yeast Bmh1 and Bmh2 isoforms 
can form stable homodimers in ∆bmh1 or ∆bmh2 single knockout strains. Blue Native Gel 
electrophoresis (BN-PAGE) was applied to answer this question. Since proteins are resolved 
in their native state, this method can reveal the ratio between proteins being in monomeric 
state versus proteins be present in multimerized state. Previously purified, untagged 14-3-3 
Figure 16: Both 14-3-3 Bmh1 and Bmh2 form homodimers with similar efficiency.
20 µg of untagged 14-3-3 isoforms were seperated by Blue Native polyacrylamide gel 
electrophoresis. A  5-18% gradient gel was used. All isoforms (except Beta, Epsilon and Eta) 
show a sharp protein band at the height of ~60 kDa, which fits the size of 14-3-3 dimers. 
To check for heterodimerization two different  14-3-3 isoforms were combined in HEPES, pH 
7.4 buffer and incubated for 1 h at 4ºC.  No additional bands could be observed by mixing 
two different 14-3-3 isoforms.
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isoforms were separated on BN-PAGE using a 5-18% gradient gel and Coomassie stained (see 
Fig. 16). To investigate heterodimerization, different isoforms were mixed and incubated for 1 
h at 4 ºC. As shown in Figure 16 all 14-3-3 proteins migrated at a height  of approximately 60 
kDa, suggesting that all 14-3-3 proteins ran as homodimers (monomer size is ~30 kDa). 
Mixed 14-3-3 proteins ran at the same height as the putative homodimers. No additional 
bands could be identified in case of mixing Bmh1 and Bmh2, showing that no exchange of 
yeast isoforms occurred in the time of 1 h at 4 ºC. 
The fact that Bmh1 and Bmh2 form equally  stable homodimers as detected by this assay, 
suggests that it is not the instability of the Bmh2/Bmh2 homodimer that causes defective 
forward transport in the ∆bmh1 strain.
4.4 Characterization of binding parameters between yeast 
14-3-3s and the tetrameric Kir6.2 tail fusion protein
4.4.1 Quantitative measurements in vitro
So far, two possible explanations for the observed isoform specificity (see Fig. 3) could be 
eliminated. First, overexpression of Bmh2 could not rescue the inability of the tetrameric 
reporter protein ccPmp2 to leave the ER in a ∆bmh1 strain. Consequentially, the difference in 
abundance of yeast 14-3-3 isoforms is not valid as an hypothesis. Secondly, no difference in 
the ability  of Bmh1 and Bmh2 to form dimers could be observed. Suggesting that it is not the 
lower Bmh2/Bmh2 homodimer stability, that causes the effect. A third hypothesis invokes 
subtle differences in binding affinity  between the tetrameric tail and the respective 14-3-3 
isoform. Two different in vitro methods have been applied to test for quantitative differences 
in binding of the yeast 14-3-3 isoforms to the tetrameric reporter protein. Using the protein, 
that I purified (see chapter 4.1) Isothermal titration calorimetry (ITC) was performed by Karl 
Duderstadt (UCSF) to obtain binding parameters for Bmh2 to the monomeric and the 
tetrameric reporter. Since no interaction could be observed for the monomeric tail of Kir6.2 
we concluded, that no binding of 14-3-3 occurred. This result underscores the observation that 
14-3-3 proteins bind the multimerized Kir6.2 tail with much higher affinity than the 
monomeric tail (see Fig. 6C in Yuan et al., 2003). In contrast, binding of Bmh2 to the 
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tetrameric tail was well detectable (see Fig. 17 A). Fitting the results to a 1:1 binding curve 
gave a dissociation constant of KD=6.2 nM. To confirm the results from ITC, the interaction 
was investigated using surface plasmon resonance (SPR) as a second method. The protein A-
ccKir6.2 fusion protein was immobilized on the surface of an CM5 Chip  (Biacore) by 
chemical crosslinking (NHS/EDC method). Defined concentrations of untagged Bmh2 protein 
(11.7-750 nM) were used to obtain binding curves which could be fitted to a 1:1 (Langmuir) 
binding model (see Fig. 17 B). The resulting dissociation constant was 17.4 nM  (+/- 0.8 nM; 
SEM). Since both methods delivered KD in the same order of magnitude, SPR was chosen to 
measure binding of Bmh1 to the tetrameric Kir6.2 fusion protein. Same concentrations and 
the same analyses were used to finally  obtain a KD value of 13.8 nM (+/- 1.2 nM; SEM) for 
the binding of Bmh1 to the tetrameric tail (see Fig. 17 B and C). Comparing the dissociation 
constants for Bmh1(13.8 nM (+/- 1.2 nM; SEM)) and Bmh2 (17.4 nM (+/- 0.8 nM; SEM)) the 
differences between both isoforms were too small to account for the differences observed for 
the localization of the ccPmp2 reporter in vivo. 
Figure 17: 14-3-3 proteins bind the tetrameric 
ccKir6.2 tail with similar affinities in vitro.
In vitro quantification of binding parameters between 
yeast 14-3-3 proteins and the tetrameric Kir6.2 tail 
fusion proteins.
(A) Using isothermal titration calorimetry: Binding 
curve for the interaction of  Bmh2 with the tetrameric 
Kir6.2 tail (performed by Karl Duderstadt at UCSF).
(B) Using surface plasmon resonance:  Binding curves 
of 14-3-3 Bmh1 and Bmh2 to the tetrameric Kir6.2 tail.
650 RU of the protein A-ccKir6.2 fusion protein were 
immobilized to the CM5 Chip (Biacore) using the N-
hydroxysucc in imide /N-e thy l -N ' - (3 -d imethy l -
aminopropyl) carbodiimide hydrochloride (NHS/EDC) 
method. Measurements were performed at  a flow-rate 
of 20 µl/min at 25° C. The chip  was regenerated with 
1.5 M MgCl2 buffer.
Curves for protein concentrations 11.7 nM to 750 nM 
are shown. X-axis show time, Y-axis show bound 
protein in Response Units (RU). Association and 
dissociation phases are displayed.
Data was analyzed with BIAevaluate 3.0 software 
(Biacore) using a 1:1 binding (Langmuir) fitting 
protocol.
(C) Summary of binding affinities for both 14-3-3 
isoforms to the ccKir6.2 tail. Dissociation constants 
(KD values) from (B) are shown as graphs. 
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4.4.2 14-3-3 Bmh1 and Bmh2 interact with the multimeric Pmp2-LRKR in 
vivo
No difference in binding affinities of the yeast 14-3-3 isoforms to the tetrameric protein A-
ccKir6.2 fusion protein could be detected in vitro. To test whether this is also true for the 
interactions in vivo, co-immunoprecipitation experiments have been performed (by K. 
Michelsen) from yeast cell extract. First of all, monomeric and tetrameric Pmp2-LRKR fusion 
protein was immunoprecipitated from a yeast wildtype strain and resulting Western blots were 
detected with an antibody recognising 14-3-3 proteins. Both yeast isoforms could be found to 
interact with the reporter fusion protein (see Fig. 18 A). As clearly shown in Figure 18 A, 
much more 14-3-3 proteins could be immunoprecipitated using the multimerized reporter, 
although the total protein amount used was less. Comparable amounts of reporter fusion 
protein were immunoprecipitated as shown in the blot detected with anti-6.2 antibody. 
Quantification of the 14-3-3 bands from three independent experiments resulted in very 
similar degrees of binding for both 14-3-3 isoforms to the tetrameric reporter (Fig. 18 B black 
bars) as well as the monomeric reporter fusion protein and 
underscore the low affinity  of both 14-3-3 proteins to the 
monomeric version (Fig. 18 B grey  bars). To furthermore 
investigate, if Bmh1 and Bmh2 bind the ccPmp2 reporter with 
similar affinities, co-IPs in the presence of only one isoform 
were done. Very comparable amounts of either Bmh1 (from 
∆bmh2 strain) or Bmh2 (from ∆bmh1 strain) were co-
immunoprecipitated with the tetrameric reporter (Figure 18 C).
Figure 18: 14-3-3 Bmh1 and Bmh2 proteins recognize  the tetrameric 
Pmp2-cc-LRKR reporter with similar affinities in vivo.
(A) Co-immunoprecipitates obtained by immunoprecipitation of the 
tetrameric (T) or monomeric (M) Pmp2 reporter fused to the tail of Kir6.2. 
Anti-Bmh blot identifies co-immunoprecipitated 14-3-3 proteins, 2% of the 
input is shown to demonstrate equal amounts of 14-3-3 proteins in the 
cellular lysates. Anti-Kir6.2-tail blot  controls for comparable enrichment of 
the two reporter membrane proteins. 
(co-IPs performed by K. Michelsen)
(B) Densitometric analysis of three independent experiments of which the 
blots  shown in (A) are representative. Values are normalized to the signals 
obtained for the monomer. 
(C) Co-immunoprecipitates obtained by immunoprecipitation of the 
tetrameric (T) from lysates of the individual 14-3-3 deletion strains. Anti-Bmh 
blot identifies the 14-3-3 proteins co-immunoprecipitated with the membrane 
protein.
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Taking quantitative in vitro and qualitative in vivo experiments together, both yeast isoforms 
bind the ccPmp2 reporter protein with same affinities in vitro and in vivo. Consequentially, the 
observed isoform specificity can not be explained by simple differences in binding.
4.5 Localization of yeast 14-3-3 proteins in the cell
The isoform specific role of yeast  14-3-3 proteins in the forward transport of the ccPmp2 
reporter could not be explained by differences in 14-3-3 protein copy  numbers, nor by 
differences in binding affinities to the multimeric reporter protein. To test whether the route of 
the reporter protein to the cell surface (for the monomeric reporter protein) or the vacuole (for 
the tetrameric version) involves packaging into COPII vesicles at ER exit sites, I transformed 
the tetrameric reporter into sec23-1 strain. This strain normally  expresses the COPII 
component Sec23 under permissive temperature (25 ºC), but  switching to the restrictive 
temperature (30 ºC or 37 ºC) leads to degradation of Sec23. As shown in Figure 19, the 
tetrameric ccPmp2-LRKR reporter protein localizes to the vacuole in the presence of Sec23 
Figure 19: The Pmp2cc-YFP-LRKR reporter travels via COPII vesicles to the vacuole.
Subcellular localization of (1) tetrameric Pmp2 reporter fused to YFP and the LRKR containig tail. (left panel).  (2) 
monomeric Pmp2 reporter fused to YFP and an inactive LKKK mutant of the tail (right panel). This mutant is not 
recognized by COPI and thus constitutively leaves the ER.
Growth of the temperature sensitive sec23-1 strain at permissive temperature (25 ºC) , meaning Sec23 presece, 
leads to export of the tetrameric Pmp2-LRKR reporter to the vacuole (vac) and export  of the monomeric Pmp2-
LKKK o the plasma membrane (PM). Switching to the restrictive temperature (30 ºC), meaning no Sec23 present, 
lead to accumulation of the tetrameric Pmp2-LRKR reporter in the ER, whereas the mutated, monomeric version 
still localized to the plasma membrane (indicating that general protein transport is not massively altered).
Scale bar is 5 µm.
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under permissive temperature (Fig. 19, 25 ºC panel). However, switching to the restrictive 
temperature, meaning Sec23 being degraded, inhibited forward transport of the reporter 
protein (Fig. 19, 30 ºC panel). To exclude a drastic general effect on all cargo, a monomeric 
version of the Kir6.2 tail, where the Arg-based LRKR motif has been mutated to LKKK was 
used (see Fig. 19, right panel). This mutation prevents COPI binding to the tail, thus 
inhibiting retrograde transport back to the ER. In contrast  to the LRKR-containing tetrameric 
reporter fusion protein, Pmp2YFP-LKKK export to the plasma membrane is not  affected by 
switching to restrictive temperature, suggesting that general trafficking was not  harmed (Fig. 
19, 30 ºC panel on the right). This result shows that LRKR-reporter trafficking depends on 
functional COPII transport. Therefore, local availability of one 14-3-3 isoform, but not the 
other, at  ER exit sites could have drastic influence on transport of the reporter protein. For this 
reason, localization of both yeast 14-3-3 proteins was investigated in the cytosol and in ER-
enriched (microsomes) and Golgi-enriched membranes (see Fig. 20). In addition, subcellular 
localization studies of both isoforms were performed using indirect immunofluorescence (see 
Fig. 21).
Adjusted amounts of microsomes, cytosolic fractions and Golgi-enriched membranes from 
wildtype, ∆bmh1 and ∆bmh2 single knockout yeast strains were separated using SDS PAGE, 
blotted and detected with anti-Bmh serum. Both 14-3-3 
isoforms are present at  all three locations (Fig. 20). 
Furthermore, the ratio of Bmh1 to Bmh2 was always very 
comparable, suggesting that either isoform is excluded from specific compartments in the cell 
and both isoforms are ubiquitously present in vivo.
Immunofluorescence microscopy was used next to confirm the biochemical results. The big 
advantage of this method is, that it gives a global overview of protein localization instead of 
focussing on one specific compartment. The disadvantage is, that the observations are 
qualitative, whereas biochemical studies can be used to gain quantitative result. Using the 
Figure 20: Yeast 14-3-3 isoforms are present in cytosol, in ER enriched 
membranes and in Golgi membranes in very similar ratios.
Distribution of yeast 14-3-3 isoforms in cellular compartments: (A) Cytosol 
(5 µl of  a 1:10 dilution, 15 µg total protein), (B) ER enriched membranes (10 
µl of a 1:10 dilution,  14 µg total protein) and Golgi membranes (25 µl of a 
1:5 dilution,  17.5 µg total protein) from yeast wildtype and single knockout 
strains were seperated on a SDS PAGE gel electrophoresis, blotted and 
detected using the anti-Bmh serum produced in this work.
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anti-Bmh serum (1:2,000 dilution), that was produced in this study, Bmh1 as well as Bmh2 
could be nicely  recognized. In contrast to prior biochemical results, immunofluorescence 
microscopy showed a difference in the localization of Bmh1 and Bmh2. 14-3-3 Bmh1 was 
found to be distributed very uniformly in the cell, Bmh2 showed a less diffuse staining and 
appeared in some puncta (see Fig. 21). This result is consistent with data from Demmel et al. 
They  observe a similar pattern for Bmh2 with a 13-myc tag. Unfortunately, the nature of the 
puncta could not be linked to ER related structures when various antibodies directed against 
ER and ER-exit-site proteins were employed (data not shown).
In summary, both yeast 14-3-3 proteins show a similar localization pattern in the cell. Both 
are present in the cytosol, in ER-enriched membranes and in Golgi membranes in comparable 
levels. However, it  can not be excluded, that the punctuated appearance of Bmh2 as seen by 
immunostaining is linked to a isoform specific role in promoting forward transport of the 
ccPmp2 reporter.
Furthermore, the difference may not lie in the localization but the function of the two 
isoforms.
Figure 21: Yeast  14-3-3 isoforms localize  differently in the 
cell.
Subcellular localization of yeast  14-3-3 proteins using 
immunostaining.
14-3-3 proteins were recognized using an anti-Bmh serum 
(1:2,000 dilution).  Blue channel shows DAPI staining. Scale bar 
is 5 µm.
14-3-3 Bmh1 (in the ∆bmh2 strain) shows an equally distributed 
staining pattern. Bmh2 (in the ∆bmh1 strain) appears in some 
puncta and  shows less diffuse staining than Bmh1.
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4.6 Search for putative isoform-specific 14-3-3 partners
4.6.1 Stepwise stripping of 14-3-3 proteins from microsomes
14-3-3 proteins can modulate protein-protein interactions in many  ways. One possibility is the 
function of the dimeric 14-3-3s as scaffold proteins (see Mrowiec and Schwappach, 2006). 
Making use of their dimeric nature, they are able to recruit additional interaction partners via 
additional binding sites. Since no explanation for the described isoform specificity  in 
promoting forward transport of the ccPmp2 reporter has been found yet, the possibility of 
additionally recruited and so far unknown isoform-specific interaction partners was 
investigated next.
Several hundred interactions have been described for 14-3-3 proteins (Pozuelo Rubio et al., 
2004). Therefore, it makes sense to limit  the interaction range to specific compartments, in 
this case the ER, to focus on the binding partners which may be involved in export of the 
Figure 22: Search for putative isoform-specific 14-3-3 interaction partners by stepwise stripping of 14-3-3 
proteins from ER enriched membranes: Three potentially differential bands could be identified.
(A) Cartoon of the procedure.
(B) Adjusted amounts (50 µg of total protein) of ER enriched membranes from ∆bmh1, ∆bmh2 and ∆ndk1 
knockout  strains were treated with either DSS or BMH crosslink reagent. The samples were then consecutively 
processed with 0.5 M KoAc, 1 M NaCl and 0.1 M Na2CO3 reagents. TCA precipitats  were loaded on a SDS PAGE 
gel, seperated, blotted and detected with an anti-Bmh serum (1:1,000 dilution).
Potentially differential bands are marked by asterisks. 
A B
* *
*
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reporter protein. A sequential stripping method was used to concentrate proteins dissociating 
from ER membranes under a given salt concentration. Microsomes (Wuestehube and 
Schekman, 1992) from three single knockout strains (∆bmh1, ∆bmh2 and ∆ndk1) were treated 
with two crosslinking reagents to fix 14-3-3 interactions to its partners. Disuccinimidyl 
suberate (DSS) crosslinks proteins by reacting with primary amines, bismaleimidohexane 
(BMH) creates disulphide bonds. After crosslinking, microsomes were incubated in 0.5 M 
KoAc, followed by  treatment with 1 M  NaCl and finally with 0.1 M Na2CO3 (Fig. 22 A). 
Proteins which came off after each step were collected and analyzed by  SDS PAGE, Western 
blotting and immunodetection using the anti-Bmh serum. The final membrane pellet was used 
to check if all 14-3-3 proteins could be stripped from the membrane. A ∆ndk1 strain was used 
as a control for both yeast 14-3-3 isoforms being present. As shown in Figure 22 B, three 
specific bands could be identified. They indicate soluble proteins, that were peripherally 
associated with the membrane in ∆bmh2 microsomes (see asterisks in KoAc and NaCl treated 
gels in Figure 22 B), or with the membrane of ∆bmh1 microsomes (see asterisks in Na2CO3 
treated gel in Figure 22 B). All specific bands were only visible with DSS treated 
microsomes. The efficiency of the crosslink reaction can be judged by  the remaining, not 
crosslinked 14-3-3 bands at the hight of ~30 kDa. Similar amounts of not-crosslinked Bmh1 
and Bmh2 proteins could be stripped at all steps, showing, that not all 14-3-3 proteins could 
be crosslinked to their interaction partners. Either because necessary reaction groups were not 
available for the crosslink reagents or because a portion of 14-3-3 proteins was simply not 
protein bound. 
4.6.2 Pulldown of putative interaction partners from yeast cytosol
Besides being present on ER membranes, 14-3-3 proteins are also present in the cytosol in 
high abundance (see Fig. 20 and 21). Most  14-3-3 interactions are thought to be cytosolic, for 
which reason an additional search for putative partners was performed with yeast cytosol. 
14-3-3 Bmh1 or Bmh2 were immobilized using the same column as described in chapter 4.1. 
Yeast cytosol from a ∆bmh1∆bmh2 double deletion strain was used to prevent possible 
monomer-monomer interactions between 14-3-3 proteins. After incubation and washing, 
proteins were eluted from the column with increasing concentrations of high salt buffer (from 
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100 mM  to 1.5 M MgCl2) and samples were separated by SDS PAGE gel electrophoresis (see 
Fig. 23 A). No specific bands for Bmh1 or Bmh2 could be identified in the pulldown (see Fig. 
23 B). However, mass spectrometry analysis (performed by A. Bosserhof and T. Ruppert, 
ZMBH) of an enriched band at the height of ~85 kDa (marked by asterisk in Fig. 23 B) 
identified the protein as the COPII coat component Sec23. Assuming that  our ccPmp2 
reporter and the KATP subunit Kir6.2 leave the ER by COPII vesicles, having identified a 
component of the machinery as putative interaction partner was motivating. Especially, 
because an interaction of the yeast 14-3-3 isoforms and Sec23A and Sec23B from HeLa cell 
extract was previously described in the work of Pozuelo Rubio et al., 2004.
4.6.3 Role of 14-3-3 - Sec23 interaction in ccPmp2 forward trafficking
14-3-3 proteins interact strongly with phosphorylated motifs which were classified as mode I, 
mode II and a newly discovered mode III motifs (see Yaffe et  al., 1997; Coblitz et al., 2006 
and Figure 24 A as a summary). First, it  was tested whether the interaction of Bmh1 and 
Figure 23: Search for 14-3-3 isoform-specific interaction partners employing purified immobilized Bmh1 
and Bmh2: Both yeast 14-3-3 isoforms interact directly or indirectly with Sec23.
(A) Cartoon of the procedure.
(B) Purified 14-3-3 Bmh1 and Bmh2 proteins were immobilized on a IgG column that was saturated with protein 
A-ccKir6.2 fusion protein. The applied yeast cytosol was from a ∆bmh1∆bmh2 double deletion strain to prevent 
14-3-3 monomer to monomer interactions. Yeast proteins were sequentially eluted with 1.5 M MgCl2, seperated 
by a SDS PAGE gel electrophoresis and Coomassie stained.  Asterisk marks a protein band at the height of ~85 
kDa, which was identified by mass spectrometry (done by A. Bosserhof and T. Ruppert, ZMBH) as the COPII coat 
component Sec23.
A B
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Bmh2 with Sec23 (as described by Pozuelo Rubio et al., 2004) was conserved in yeast. 
Although no classical interaction motifs could be identified in the yeast homolog, many 
14-3-3 interacting proteins bind to variants of the canonical motifs, or even very different 
motifs (Yaffe et al., 2002). Therefore, the consensus sequence was relaxed and up to three 
residues preceding the required Proline were allowed. As a result, two highly conserved 
sequences were identified: A N-terminal sequence (RNSSWSCP) and a C-terminal sequence 
(RFLLSKLNP). To test if mutation of one or both putative 14-3-3 binding motifs affected 
trafficking of the multimeric reporter protein, either one or both essential Serines in the motifs 
were mutated to Asparagines. The mutants were then transformed into a temperature-sensitive 
sec23-1 strain. This strain allows to control the stability of the temperature sensitive Sec23 
protein by growth temperature. At permissive temperature (20 ºC) wildtype Sec23 protein is 
expressed, at restrictive temperature (30 ºC or 37 ºC) the wildtype protein is degraded. 
Expression of the two single mutants (S79N and S726N) as well as the combination of both 
supported the survival of the sec23-1 strain at restrictive temperature (Fig. 25). This was 
particularly important to demonstrate, since the mutation in the C-terminal region could have 
severely interfered with the essential Sec23-Sar1 interaction and consequentially cell growth 
(see Bi et al., 2002). 
But do the mutations specifically interfere with the transport of the tetrameric reporter 
protein? To answer this question the ccPmp2-YFP reporter was coexpressed with the Sec23 
Figure 24: Two putative  14-3-3 binding motifs are highly 
conserved in Sec23 homologues.
(A) Classical 14-3-3 binding motifs derived from studies 
addressing the interaction of mammalian 14-3-3 proteins.
All three classical 14-3-3 binding motifs are phosphorylation 
dependent motifs.
Mode I and mode II binding motifs show Proline two amino 
acids C-terminal to the phosphorylated Serine or Threonine, 
mode III  shows the phosphorylated Serine or Threonine one or 
two amino acids to C-terminus of the protein. There seems to 
be a preference for aromatic or aliphatic side chains in mode II.
Although strongly favoured, the amino acid distribution in the 
consensus sequences is not  required for 14-3-3 binding. Many 
14-3-3 binding sites differ from the classical binding motifs.
(B) Alignment of two putative 14-3-3 binding motifs in the N-terminus (RFTWNVFP) and in the highly conserved 
C-terminus (RFLLSKLNP) of Sec23 proteins.
The most important aspects of the 14-3-3 binding motifs are conserved: Arginine at position 1,  Serine or 
Threonine that can be phosphorylated and Proline at the end of the motif.
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mutant versions in the sec23-1 strain and its localization was investigated by life cell imaging 
(Fig. 26). 
In presence of the wildtype Sec23 protein (at 20 ºC) the reporter left the ER very efficiently as 
shown by the vacuolar staining in all strains (Fig. 26, upper panel). Switching to 30 ºC has a 
strong effect on all mutant expressing strains. Both strains expressing the single mutants 
(S79N and S726N) lost their exclusively  vacuolar staining and the reporter could be partially 
Figure 26: Mutations in the  putative  14-3-3 binding sites of yeast  Sec23 impair forward transport of the 
tetrameric Pmp2ccYFP reporter.
Fluorescent  images of life cell imaging show the localization of the Pmp2ccYFP reporter in the absence (at  30 ºC 
- restrictive temperature) or presence (at 20 ºC - permissive temperature) of endogenous Sec23. The empty 
plasmid (BFGII only) was used as negative control.
Scale bar is 5 µm. Vacuole (vac) and ER (ER) are marked with arrows.
Figure  25: All Sec23 mutants with 
altered putative  14-3-3 interaction 
motifs support the survival of a 
temperature sensitive  sec23-1 strain at 
the restrictive temperature.
Growth of temperature-sensitive sec23-1 
strain transformed with different SEC23 
mutants. Cells were di luted to an 
OD600=0.5 and diluted 1:10 and 1:100. 10 
µl of each cell concentration was spotted 
on plates lacking Leucine and grown at 
permissive temperature (20 ºC) and 
restrictive temperature (37 ºC) for 3 days. 
The empty plasmid was used as negative 
control, a plasmid containing the wildtype 
SEC23 was used as positive control.
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found in the ER as well (Fig. 26, 30 ºC panel for S79N and S726N). The effect seemed to be 
additive, since combination of both mutants led to total mislocalization of the reporter (see 
Fig. 26, 30 ºC panel for S79N/S726N).
Taken together, both 14-3-3 Bmh1 and Bmh2 were found to interact with Sec23 from yeast 
cytosol. Mutations in two putative binding regions in Sec23 supported cell growth but 
interfered with the transport of the ccPmp2 reporter in vivo. Combining both mutations led to 
strong accumulation of the reporter in bright, punctate structures.
4.6.4 Isoform specificity maps to the 14-3-3 C-termini
Yeast 14-3-3 isoforms Bmh1 and Bmh2 are 81% similar (see alignment in Fig. 27 A). It may 
therefore be surprising to see isoform specific differences between the two proteins. Main 
differences can be found in the distal C-termini (Fig. 27 A). To follow the idea that isoform 
specificity might map to the 14-3-3 C-termini, chimeric proteins were created by exchanging 
the last 69 amino acids of Bmh1 with the last 75 amino acids of Bmh2 and vice versa. This 
resulted in two 14-3-3 versions: (1) H1N2C: Bmh1 N-terminus with Bmh2 C-terminus and 
(2) H2N1C: Bmh2 N-terminus with Bmh1 C-terminus. The chimeric variants were 
coexpressed with the ccPmp2-YFP reporter protein in the background of a double deletion 
strain ∆bmh1∆bmh2. In this strain Michelsen et al. showed an accumulation of the reporter in 
the ER due to the lack of 14-3-3 proteins (Michelsen et al., 2006). First, trafficking was 
checked by  expression of the functional Bmh1 isoform as a positive control. As expected, the 
tetrameric reporter localized exclusively  to the vacuole of the cell (see Fig. 27 B, left panel), 
consistent with its localization in the ∆bmh2 background. Vacuolar staining was also observed 
for the 14-3-3 chimera H2N1C (Fig. 27 B, central panel), but  not for the chimeric H1N2C 
variant (Fig. 27 B, right panel). In this case, the reporter localised to the ER only, meaning 
that replacement of the C-terminal Bmh1 region by  the distal Bmh2 C-terminus abolished the 
positive function of Bmh1 in promoting ER exit of the reporter. Thus, isoform specific 
behaviour in its effect on ccPmp2 forward trafficking was determined by the 14-3-3 C-
termini.
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4.6.5 C-termini of 14-3-3 Bmh1 and Bmh2 interact with Ndk1
Coming from the findings of the previous chapter, the apparent question was: How can 14-3-3 
isoforms achieve different functionality through their small C-terminal ends?
These regions are neither involved in the recognition of phosphorylated binding motifs, nor 
do they participate in dimer formation (see Fig. 27 A). To test  whether they might be involved 
in recruitment of additional proteins a pulldown experiment with yeast cytosol was 
performed. In contrast to the pulldown experiment shown in chapter 4.6.2, only GST-tagged 
Bmh1- or Bmh2-C-termini were immobilised on GSH-agarose. Since the region which forms 
Figure 27: The stimulatory effect  of 
Bmh1 on forward transport of the 
multimeric reporter protein maps 
to the C-terminus.
(A) Al ignment of yeast 14-3-3 
isoforms Bmh1 and Bmh2.
E s s e n t i a l r e g i o n s f o r 1 4 - 3 - 3 
dimerisation,  binding of 14-3-3 mode 
I,  II or III  binding motifs, the poly-Q 
stretch in Bmh2 and the C-terminal 
regions that have been swapped to 
create chimeric 14-3-3 proteins are 
highlighted. 
(B) Fluorescent images of life cell 
imag ing show the t e t ramer i c 
Pmp2ccYFP-RKR or -KKK reporter in 
a ∆bmh1∆bmh2 double deletion strain 
expressing the indicated chimeric 
14-3-3 variants.
Vacuole (vac) and ER (ER) are 
accentuated by arrows. Scale bar is 5 
µm.
A
B
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the 14-3-3 binding groove is not present in this constructs, the experiment was specifically 
designed to identify putative binding partners that would recognise one but not the other 
14-3-3 C-terminus. This allowed a much more specific search for new putative interaction 
partners, which do not depend on the binding groove and followed up  the idea of 
simultaneous binding of 14-3-3s to the Arg-based motif of the membrane protein and 
simultaneous recruitment of additional machinery (by the distal C-terminus). The 
experimental setup is described in Figure 28 A. First, purified yeast cytosol was used as input, 
the column was washed and 300 mM  MgCl2 in washing buffer was used for elution. No 
isoform specific bands could be identified after seperation by  SDS PAGE and Coomassie 
Figure 28: The C-termini of 14-3-3 Bmh1 and Bmh2 interact  directly with the nucleoside diphosphate 
kinase Ndk1.
(A) Cartoon of the procedure.
(B) GST tagged Bmh1- and Bmh2-C termini were immobilized on a GSH-agarose column. The column was 
incubated with yeast cytosol,  washed and eluted with 300 mM MgCl2. Elutions were seperated on a 13.5% SDS 
PAGE gel and detected with an anti-Ndk1 antibody (1:1,000 dilution).  Ndk1 was highly enriched from yeast 
cytosol. The amount of bound Ndk1 was slightly more in the case when Bmh1 C-terminus was immobilized. No 
binding was observed without immobilized 14-3-3 C-termini.
Specific Ndk1 detection followed enrichment from yeast cytosol and identification by mass spectrometry (data not 
shown).
(C) C-termini of yeast 14-3-3 proteins interact directly with Ndk1.
GST tagged Bmh1- and Bmh2-C termini were immobilized on a GSH-agarose column. The column was 
incubated with purified Ndk1-H6, washed and eluted with 300 mM MgCl2. Elutions were seperated on a 13.5% 
SDS PAGE gel and detected with an anti-Ndk1 antibody (1:1,000 dilution).
Both 14-3-3 isoforms bind Ndk1 directly. No binding was observed without immobilized 14-3-3 C-termini.
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staining. But one protein band at the height of ~15 kDa was highly  enriched when the C-
termini of Bmh1 and Bmh2 were immobilised (data not shown). The band was absent when 
only GST was exposed, indicating a specific interaction for the yeast 14-3-3 C-termini. Mass 
spectrometry  analysis (performed by T. Ruppert  and A. Bosserhof, ZMBH) identified the 
band as nucleoside diphosphate kinase (Ndk1). This protein catalyses the transfer of gamma 
phosphates from nucleoside triphosphates to nucleoside diphosphates (Palmieri et al., 1973; 
Jong and Ma, 1991; Fukuchi et al., 1993). Interestingly, the human homolog Nm23H2 was 
shown to play a role in the formation of COPII vesicles in mammalian cells (Kapetanovich et 
al., 2005). Mass spectrometry results were confirmed by detection of the highly  enriched 
Ndk1 band using an anti-Ndk1 antibody  (Pain lab; see Figure 28 B). To test if binding of 
Ndk1 to the 14-3-3 C-termini was direct, the experiment was repeated with purified, His-
tagged Ndk1 protein as input. Again, strong binding of Ndk1 to the 14-3-3 C-termini was 
observed and the interaction was dependent on the presence of either Bmh1- or Bmh2-C-
terminus since no Ndk1 was bound when using immobilised GST or empty beads (see Fig. 28 
C). 
In summary, both yeast 14-3-3 C-termini interact with the nucleoside diphosphate kinase 
(Ndk1) by direct binding. The connection of 14-3-3 proteins to Ndk1 furthermore 
strengthened the notion that there could be a link between Bmh1 and Bmh2 to ER exit via 
COPII vesicles.
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4.7 Role of 14-3-3 proteins in COPII budding
4.7.1 Bmh1 is required for efficient COPII budding
In their work Kapetanovich et al linked the nucleoside diphosphate kinase Nm23H2, a human 
homolog of the yeast Ndk1 protein, to ER export. They  made use of a COPII assembly assay 
in digitonin-permeabilized cells to identify cytosolic factors involved in ER exit site 
formation or COPII assembly. They showed that Nm23H2 supports efficient COPII vesicle 
formation. In my work I found the yeast Ndk1 to interact with the C-termini of 14-3-3 
proteins Bmh1 and Bmh2. The interaction was direct and Ndk1 was highly enriched from 
yeast cytosol. To ask whether 14-3-3 proteins or a complex of 14-3-3 with Ndk1 have a role 
in COPII vesicle formation as well, an in vitro budding assay was performed. For this, ER 
enriched membranes were purified from wildtype and 14-3-3 single knockout strains and 
incubated with yeast cytosol in the 
presence of energy and Sar1 protein 
(see Figure 29 for details). Energy 
and Sar1 addition strongly promote 
COPII vesicle formation (see Lee et 
al., 2004 for review). Formed 
vesicles were separated from 
m i c r o s o m e s b y d i f f e r e n t i a l 
cent r i fugat ion , co l lec ted and 
analysed by SDS PAGE and 
immunoblot with antibodies against a 
COPII coat component (Sec24), ER-
Golgi v-SNARES (Sec22, Bos1), a 
cargo that cycles between the ER and 
the cis-Golgi (Emp47), the tetrameric 
ccPmp2 reporter and Bmh1/2. The 
result for microsomes from wildtype 
cells (see Figure 30 A) suggested that both 14-3-3 isoforms were present on formed COPII 
vesicles, as confirmed by the strong accumulation of the COPII coat component Sec24 in the 
Figure 29: Cartoon of COPII budding assay.
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same fraction. Both cargo proteins, the reporter protein ccPmp2-YFP as well as Emp47, were 
efficiently packaged. Performing the budding assay in the absence of Bmh2 did not influence 
budding efficiency compared to wildtype (Fig. 30 B, ∆bmh2 lanes). However, lack of Bmh1 
lead to strongly reduced packaging (approx. 10 fold reduction; see ∆bmh1 lanes in Fig. 30 B 
Figure 30: Bmh1 is required for efficient formation of COPII-coated vesicles in vitro.
Immunoblots of COPII components and cargo proteins in ER donor membranes and vesicles formed during the 
budding reaction. Donor membranes were incubated for 30 min at  30 ºC. Formed vesicles were collected from 
the low spin supernatant of the budding reaction by high speed spin (100,000x g for 40 min).
“-“  indicates vesicle formation in the presence of cytosol only, “+” indicates inclusion of cytosol (20 µg of total 
protein per reaction), purified Sar1 (100 ng of purified protein per reaction), GTPγS (2 mM end concentration in 
each reaction) and an ATP-regeneration system. The total volume per reaction was 50 µl.
Proteins were separated on a 13.5% SDS PAGE gel, blotted and detected with various antibodies (marked with 
arrows).
(A) COPII budding of wildtype microsomes and wildtype cytosol.
(B) COPII budding of 14-3-3 single knockout strains.
(C) The effects were quantified from 4 independent experiments (employing three independently prepared 
batches of microsomes) for the COPII component Sec24 and normalized to the highest signal obtained (∆bmh2). 
Error bar indicates standard error.
A B
C
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and graphs in Fig. 30 C). This is consistent with the results from life cell imaging, where a 
∆bmh1 strain is unable to promote forward transport of the reporter protein from the ER.
The possibility  to combine microsomes and cytosol from different  knockout strains allowed 
me to ask whether budding differences depend on Bmh1 presence on the donor membranes, 
or if cytosolic Bmh1 has an impact on the budding mechanism. Data from several 
independent experiments was summarised in Figure 30 C. The graph clearly shows, that 
addition of cytosolic Bmh1 to the budding reaction could not rescue the failure in COPII 
vesicle formation of the ∆bmh1 strain. On the other hand, lack of cytosolic Bmh1 decreased 
budding efficiency by approx. 50% compared to ∆bmh2. Still, presence of Bmh1 on the donor 
membrane seemed to be more relevant than cytosolic Bmh1 (as measured by Sec24 presence 
on formed COPII vesicles). 
Unexpectedly, effects of Bmh1 in COPII budding were not limited to the Pmp2 reporter, but 
were relevant for packaging of other cargo (here: Emp47) and for the enrichment of coat 
components, implying that the defect in the ∆bmh1 strain is general to the process of COPII 
vesicle formation.
4.7.2 Effects of 14-3-3 Bmh1 on trafficking of cycling cargo
Lack of Bmh1 leads to reduced competitive fitness (Giaever et al., 2002) and the ∆bmh1 
strain showed slower growth than wildtype (data not shown). But nevertheless, this strain is 
perfectly  viable. It seemed hard to believe, that the very strong general effect of Bmh1 on 
COPII budding influences all COPII cargo proteins. In contrast, it  seemed more likely, that 
only a subclass is affected. Life cell imaging studies were performed to monitor the 
localisation of three different GFP fusion proteins. First, Pmp2GFP-LRERS, a monomeric 
Pmp2 reporter exposing a COPI retrieval signal of intermediate efficacy (Michelsen et al., 
2006), second, Gef1-GFP, a voltage-gated chloride channel localized to the Golgi 
(Schwappach et al., 1998) and third, CPY-GFP, a carboxypeptidase Y localised to the vacuole 
(Westphal et al., 1996). 
In contrast to the Pmp2 reporter, Gef1 and CPY do not cycle, due to the lack of the Arg-based 
motif or other retrieval signals.
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In a wildtype strain, all three proteins localised as expected (see Fig. 31, left panel). 
Trafficking of neither protein was influenced by the knockout of 14-3-3 Bmh2 (see Fig. 31, 
right panel). However, in a ∆bmh1 strain localisation of the Pmp2GFP-LRERS reporter 
changed from a vacuolar to more ER staining, whereas both non-cycling proteins showed 
identical staining patterns compared to wildtype (see Fig. 31, panel for ∆bmh1). This result 
restricted the role of Bmh1 in vivo to cycling cargo proteins.
4.7.3 A dual role for Bmh1 in COPII packaging
To provide more evidence for the requirement of Bmh1 on the donor membrane for efficient 
COPII vesicle formation, budding was monitored in more detail by using an antibody against 
the Kir6.2 subunit to detect packaging of the reporter, an antibody  recognising the ER-Golgi 
v-SNARE Bos1 and the anti-Bmh serum (see Fig. 32). As already summarised (graph in Fig. 
30 C) the COPII coat component  Sec24 was strongly concentrated on vesicles formed from 
Bmh1 microsomes and less abundant when Bmh2 microsomes were used (see lanes where 
cytosol and energy was added, marked with grey background and by  arrows). Indicating, that 
Figure 31: General role of Bmh1 in 
ER exit of cycling cargo in vivo.
An ER retrieval signal renders cargo 
sensitive to BMH1 deletion in vivo.
Fluorescent images of life cell 
imaging show the localization of 
different cargo proteins in the 
respective 14-3-3 deletion strains. 
The cycling,  monomeric Pmp2 
reporter Pmp2GFP-LRERS exposes 
a C O P I r e t r i e v a l s i g n a l o f 
intermediate efficacy (Michelsen et 
al., 2006). Knock out of Bmh1 
(∆bmh1) but not Bmh2 (∆bmh2) 
leads to a steady state localization 
of the reporter in the ER.
Gef1 and CPY do not cycle due to a 
lack of a ER retrieval signal and are 
localised to the Golgi (Schwappach 
et  al., 1998) and the vacuole 
(Westphal et al., 1996).  Their 
localization is not dependent on the 
presence of either 14-3-3 isoform.
Arrows indicate the vacuole (vac) or 
the perinuclear ER (ER).  Scale bar 
is 5 µm.
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Bmh1 may have a role in recruiting or stabilising COPII component on the vesicles. On the 
other hand, high amounts of Sec24 and Bos1 were also recruited without energy  addition for 
budding reactions where Bmh1 was added to the cytosol (see Fig. 32, green boxes). 
Suggesting that Bmh1 may be relevant for recruitment of COPII components from the 
cytosol. Interestingly, strong stimulation of cargo packaging (see Fig. 32, ccKir6.2 detection) 
was only achieved with Bmh1 microsomes and Bmh1 cytosol and the addition of cytosol and 
energy. 
Some packaging however, could be observed with Bmh1 microsomes per se as they packaged 
low amounts of reporter protein when only energy was added. In this case the ratio of 
packaged cargo to Sec24 was very high, implying that very dense vesicles had been formed 
(see Fig. 32, red box). 
Detection for 14-3-3 proteins showed strong enrichment of Bmh1 and Bmh2 on the vesicles 
from added cytosol. Although both 14-3-3s were present on donor membranes in significant 
Figure 32: Presence  of Bmh1 on the donor membrane  is required for stimulation of COPII-coated vesicles 
formation and reporter packaging in vitro.
Immunoblots of COPII components and cargo proteins in ER donor membranes and vesicles formed during the 
budding reaction. 
Purified Sar1 protein was added into all reactions. "+" energy indicates the addition of GTPγS and an ATP 
regeneration system.
See description of Figure 30 for more detail.
Most important lanes and detected proteins are highlighted by grey background and arrows.
series 1 2 3 4
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amounts, they made only a small proportion of the total 14-3-3s on formed vesicles and were 
hard to detect at all (see Fig. 32: missing Bmh1 band in series 1 and missing Bmh2 band in 
series 3).
Can addition of purified Bmh1 to the budding reaction rescue the packaging defect of the 
∆bmh1 strain?
For this purpose Bmh1 and Bmh2 microsomes were incubated with Bmh2 cytosol in the 
presence (+ Bmh1) or absence (- Bmh1) of purified Bmh1 protein (Fig. 33). Vesicles were 
analysed by antibodies detecting Sec24, Emp47 (as cargo), Bip (as ER localised protein, not 
processed by COPII) and the ER-Golgi v-SNARE Sec22 and Bos1 (see Fig. 33). As 
previously  shown, Bmh2 microsomes with Bmh2 cytosol did not promote packaging at all 
(see Fig. 33, series 4). Microsomes containing Bmh1 allowed formation of some vesicles and 
some reporter packaging (see Fig. 33, series 2). This was consistent with results from former 
budding assays (shown in Fig. 32). Addition of Bmh1 in the background of Bmh2 cytosol 
strongly enhanced the ability of packaging the cargo protein into COPII vesicles (see Fig. 33, 
lanes marked by grey background and arrows), but it did not enhance Sec24 enrichment to the 
Figure 33: Addition of Bmh1 to the in vitro packaging assay can partially rescue the defect  of a ∆bmh1 
strain.
Immunoblots of COPII components and cargo proteins in ER donor membranes and vesicles formed during the 
budding reaction. 
See description of Figure 30 for more detail.
No cytosolic Bmh1 was present. "+ Bmh1" indicates the addition of purified Bmh1 protein to the budding reaction. 
Most important lanes and detected proteins are highlighted by grey background and arrows.
series 1 2 3 4
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same extent. Only a weak Sec24 protein band could be detected upon Bmh1 addition when 
only Bmh2 was present in donor membranes and cytosol, although Emp47 was efficiently 
packaged into vesicles (see Fig. 33, series 3).
Taken together, only  Bmh1 promoted COPII budding in vitro. Packaging of the reporter 
protein was already detected when Bmh1 microsomes were incubated with energy and further 
stimulation was achieved when Bmh1 containing cytosol was added. These findings suggest a 
dual effect of Bmh1 on COPII budding, which is dependent on whether Bmh1 is membrane 
bound or cytosolic.
4.7.4 Ndk1 deletion does not affect COPII budding
14-3-3 Bmh1 was shown to promote COPII vesicle formation. Furthermore, Bmh1 and Bmh2 
C-termini were found to interact directly with the nucleoside diphosphate kinase (Ndk1) from 
yeast. The human homolog of Ndk1, Nm23H2, was previously described to have an influence 
on COPII export from the ER in mammalian cells (Kapetanovich et al., 2005). The resulting 
question was, if the effects of Nm23H2 are transferable to yeast and if the role of 14-3-3 
proteins is linked to Ndk1. In other words: Does Ndk1 participate in the mechanism of COPII 
vesicle formation?
First, the presence of Ndk1 on ER enriched membranes was confirmed by Western blot 
detection with a HA-antibody. Therefore, Ndk1 was genomically  HA-tagged to improve 
antibody detection, since the endogenous protein is only present in low copy numbers and 
was not detectable on membrane fractions using a Ndk1 specific antibody. As shown in 
Figure 34, endogenous Ndk1-HA was found on ER enriched membranes. However, no 14-3-3 
isoform specific membrane association could be identified (see Fig. 34: Ndk1-HA band in 
∆bmh1 and ∆bmh2 microsomes). No band was visible neither for microsomes from a 
Figure 34: Ndk1 is present on microsomes.
5 µl of ER enriched membranes (total protein concentration 1.25 µg/
µl each) were loaded on a 13.5% SDS gel separated, blotted and 
detected with anti-HA antibody.
Ndk1 protein was genomically HA-tagged to improve signal-to-noise 
in Western blot detection.  Ndk1 presence on microsomes is not 
influenced by the lack of either 14-3-3 isoform.
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wildtype strain, expressing Ndk1 that was not HA-tagged, nor for microsomes from a strain 
lacking Ndk1 (∆ndk1).
Ndk1 is best characterised in its function to catalyse the transfer of gamma phosphates from 
nucleoside triphosphates to nucleoside diphosphates (Jong and Ma, 1991; Fukuchi et al., 
1993). This enzymatic activity relies on an intermediate self-phosphorylation step of a central 
histidine residue in Ndk1. Previous findings revealed that mutating the critical His119 residue 
leads to loss of Ndk1 enzyme activity (Amutha and Pain, 2003). According to Kapetanovich 
et al the role of Nm23H2 does not require the enzyme activity. The authors speculate that 
Nm23H2 may have a structural role in ER exit site formation instead. To test this hypothesis 
in vitro, the COPII budding assay was performed in the presence of GDP instead of non-
hydrolysable GTPγS. The purpose was to make budding dependent on the enzyme activity of 
Ndk1 to synthesise GTP from ATP, since GTP is needed for COPII vesicle formation. A 
wildtype strain was compared to a strain lacking Ndk1 (∆ndk1). 
As shown in Figure 35, deletion of Ndk1 did not interfere with COPII budding at all. Addition 
of energy and Sar1 (see Fig. 35, green box) was sufficient to obtain enrichment of Sec24 and 
COPII specific SNARES (see Fig. 35, Bet1 and Bos1 detection) on the vesicles and efficient 
packaging of both reporter proteins (see Fig. 35, Emp47 and ccPmp2 detection). Both, ∆ndk1 
and wildtype strains showed a very similar budding behaviour and were not affected by 
absence or addition of neither Sar1, Ndk1 nor its mutated version (mut.). There might 
however be a slight stimulation of reporter packaging by  addition of Ndk1 or its mutant 
Figure 35: Absence of Ndk1 leads to very efficient COPII budding in vitro; No Ndk1 nucleoside 
diphosphate enzyme activity is needed for efficient COPII budding.
Immunoblots of  COPII components and cargo proteins in ER donor membranes and vesicles formed 
during the budding reaction. 
Details as described in Figure 30 except for the usage of GDP instead of GTPγS.
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version in the absence of added recombinant Sar1. This seemed very  surprising, since Sar1 
addition is required for COPII vesicle formation in the in vitro budding assay.
4.7.5 Ndk1 and 14-3-3 Bmh1 are required in combination for efficient 
COPII vesicle formation
Since 14-3-3 Bmh1 showed a strong effect on COPII budding I tested the ∆ndk1 strain for a 
comparable effect. As shown in the previous chapter, the knockout had no effect on vesicle 
formation in the in vitro assay. However, the detected interaction between Ndk1 and 14-3-3 
proteins encouraged me to investigate the behaviour of double-knockout strains where Ndk1 
knockout was combined with either Bmh1 or Bmh2 deletion (resulting in ∆ndk1∆bmh1 and 
∆ndk1∆bmh2 strains respectively). Again, the in vitro COPII budding assay was performed as 
described in 4.7.1. 
First, budding of the ∆ndk1 strain was monitored in the presence of GTPγS. Results obtained 
were consistent with previous results (see Fig. 35). Surprisingly, budding in the absence of 
Ndk1 and Bmh1, meaning only  Bmh2 was present (see Fig. 36 B), was very efficient. This 
result inverted what had been obtained with the ∆bmh2 strain, which was incapable of 
forming COPII vesicles in vitro during the timeframe of the experiment (see Fig. 30 B). In the 
∆ndk1∆bmh1 background, no stimulation could be achieved by addition of either Sar1, Ndk1 
or the Ndk1 mutant  (Fig. 36 B: see constantly efficient recruitment of Sec24, SNARES and 
cargo). Budding behaviour in the presence of only Bmh1, but not Ndk1 and Bmh2 
(∆ndk1∆bmh2 strain, Fig. 36 C) diverged completely from the ∆ndk1∆bmh1 strain in the way, 
that vesicle formation was dependent on the addition of Ndk1 protein or the enzymatic 
inactive mutant (see Fig. 36 C: lanes marked with grey background and arrows). Adding only 
Sar1 into the reaction did not promote budding. On the other hand, addition of only Ndk1 or 
the mutant was sufficient for efficient budding, thus no added Sar1 was needed. 
In summary, I conclude that  the positive effect of 14-3-3 Bmh1 on COPII budding depended 
on the presence of Ndk1, whereas Bmh2 in combination with Ndk1 negatively interfered with 
vesicle formation. The results also suggest, that Bmh2 alone has a positive effect on budding.
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Figure 36: Ndk1 and Bmh1 (but  not  Bmh2) are required in combination for efficient COPII budding in 
vitro.
Immunoblots of  COPII components and cargo proteins in ER donor membranes and vesicles formed during the 
budding reaction. 
Details as described in Figure 30. 
Sar1 (100 ng per reaction), Ndk1 and an enzymatic inactive Ndk1 mutant (mut.) (each 15 µg per reaction) were 
added into the budding reaction (+) or were absent (-).
Most important lanes and detected proteins are highlighted with grey boxes and arrows.
(A) In vitro COPII budding assay was performed in a ∆ndk1 strain with both 14-3-3 isoforms present.
(B) In vitro COPII budding assay was performed in a ∆ndk1∆bmh1 strain with only  14-3-3 Bmh2 present.
(C) In vitro COPII budding assay was performed in a ∆ndk1∆bmh2 strain  with only 14-3-3 Bmh1 present.
In the presence of  both 14-3-3 isoforms Bmh1 and Bmh2 (∆ndk1) no stimulation of budding or reporter 
packaging can be observed by adding Ndk1. Budding and packaging is efficient  when Bmh1 and Ndk1 are 
missing (∆ndk1∆bmh2). Addition of purified Ndk1 or its enzymatic inactive mutant highly stimulates budding in a 
strain lacking Bmh2 (∆ndk1∆bmh2).
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4.7.6 Quantification of Sec24 levels on the donor membranes
The surprising differences between both double-deletion ∆ndk1∆bmh1 and ∆ndk1∆bmh2 
strains and the respective single deletion strains ∆bmh1 and ∆bmh2 could be a result of 
different amounts of COPII components present on the donor membranes. For this purpose, 
microsomes from six yeast strains, that  had been used in this work were analysed and Sec24 
levels were compared (see Fig. 37). Analogous to previously  obtained results, yeast strains 
which budded worst (∆bmh1 and ∆ndk1∆bmh2) had low levels of Sec24 on their donor 
membranes and strains which were efficient in budding had high amounts of Sec24 present 
(see Fig. 37 wildtype, ∆bmh2, ∆ndk  and ∆ndk1∆bmh1). Thus, the observed isoform specific 
differences in promoting COPII vesicle formation might be due to differences in abundance of 
COPII components on ER membranes.
Figure 37: Sec24 is not  equally present on ER 
enriched donor membranes in various knock 
out strains.
Character izat ion of ER enr iched donor 
membranes used for in vitro COPII budding 
assays. Microsomes from various strains 
(adjusted to 14 µg of total protein each) were 
resolved on a 13.5% SDS PAGE gel, blotted and 
detected with the indicated antibodies.
The strain lacking Bmh1 (∆bmh1) and the strain 
having Bmh1 but  not Ndk1 (∆ndk1∆bmh2) have 
strongly decreased levels of Sec24 present on the 
ER enriched donor membranes.
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5. Discussion
14-3-3 proteins have been described to play a crucial role in the trafficking of various 
membrane proteins. Examples are the GABAB receptor, K+ channels TASK-1 and TASK-3, 
the invariant chain of the MHCII complex and a number of reporter proteins presenting the C-
terminus tail of Kir6.2, a subunit of the ATP sensitive potassium channel (KATP) (see Table 1 
for details). All these proteins have in common that they are multimers and expose a COPI-
interaction motif in addition to a 14-3-3 recognition site. The increasing number of 14-3-3 
interactions with these proteins underscores the importance of 14-3-3s in regulation of 
multimeric membrane protein trafficking. However, little is known about mechanistic details 
of the interactions between 14-3-3 isoforms and membrane proteins. Especially the role of 
14-3-3 isoform specificity has not been addressed yet. 
In my study I made use of a well defined reporter system, where the last 36 amino acids of 
Kir6.2 were fused to the isoproteolipid Pmp2, a type-I membrane protein in yeast. Usage of 
the yeast system allowed me to combine biochemical and in vivo methods. My work resulted 
in further insights into the function of 14-3-3 proteins in KATP trafficking as I could define the 
step of forward transport at which isoform specific 14-3-3 function occurs and identify the 
region in the yeast Bmh1 isoform that creates isoform specificity.
The nucleoside diphosphate kinase Ndk1 was found to interact with the Bmh1 and Bmh2 C-
termini. The putative roles of 14-3-3s and Ndk1 will be discussed in this chapter.
5.1 The role of 14-3-3 proteins in forward trafficking is 
isoform specific
As shown by Michelsen and colleagues only Bmh1 but not Bmh2 can promote forward 
transport of the tetrameric Pmp2 reporter (see Fig. 3). Examples of isoform specificity of 
14-3-3 proteins are rare. The human isoform 14-3-3 Sigma was shown to specifically 
facilitate cytokinesis (Wilker et al., 2005). The authors solved the X-ray crystal structure of 
the human 14-3-3 Sigma and identified an isoform specific binding site that is involved in 
specific ligand discrimination of the 14-3-3 Sigma isoform. Mutation of the involved residues 
85
to the sequence that is present in all other isoforms, replaced the specific binding capability of 
14-3-3 sigma. Paul et al found 14-3-3 isoforms to be localized differently in plant cells and 
propose subcellular localization as one way to facilitate isoform specificity (Paul et al., 2005). 
In yeast, other groups have previously presented results that point towards putative negative 
effects of Bmh2 in the cell. First, Demmel et  al showed that Bmh2 localizes differently  than 
Bmh1 in small puncta. Since they were using a 13-myc tag, that could potentially  influence 
subcellular localization, I decided to repeat this analysis by immunofluorescence microscopy 
using untagged Bmh1 and Bmh2. Although the differences in staining patterns were not as 
pronounced, results could be confirmed (see Fig. 21). One can speculate that Bmh2 puncta are 
small aggregates that result from the interactions of the C-terminal poly-Q stretches of Bmh2 
homodimers. The poly-Q stretch is only  present in Bmh2 but not Bmh1. Secondly, Roth and 
colleagues reported that overexpression of the Bmh2 C-terminus is toxic and cells failed to 
polarize vesicular transport. Moreover, overexpression of Bmh2 caused damage to the ER 
structure. This was consistent with my  observations (see Fig. 15). Finally, ∆bmh1 cells grew 
significantly slower than wildtype or ∆bmh2 cells and their competitive fitness is reduced 
(Giaever et al., 2002; data not shown). Taking into account, that 14-3-3 proteins are believed 
to be present and functional only in dimeric form, as homo- and heterodimers, the number of 
Bmh2 homodimers in the ∆bmh1 strain increased by 412%, whereas Bmh1 homodimers 
increased only  by  80% in the ∆bmh2 background (see Table 3 B). Nevertheless, the total 
number of Bmh2/Bmh2 homodimers in a ∆bmh1 strain replaces only ~36% of total 14-3-3 
dimers in a wildtype strain. 
Combining my findings with the information provided by  other groups, a dominant negative 
effect of Bmh2 on the regulation of the forward transport of ccPmp2 could contribute to the 
observed isoform specificity. 
Still, overexpression of Bmh2 in the ∆bmh1 background could not rescue the loss of Bmh1 
(see Fig. 15 A), implying a functional difference between the two isoforms.
Even though immunofluorescence provides a global overview of the localization of a protein 
within the whole cell, it  was particularly difficult for either 14-3-3 isoform to identify 
compartments in which one, but not the other isoform was localised or enriched. This can be 
explained by the high expression levels of both proteins and their large cytosolic pool (see 
Fig. 21). In addition, the small size of yeast cells limits the resolution. Therefore, I 
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complemented microscopy  data with Western blot detection of Bmh1 and Bmh2 in ER- and 
Golgi-enriched membranes in comparison to cytosolic 14-3-3 abundance (see Fig. 20). It was 
surprising to see that both isoforms are present  on ER and Golgi membranes in high amounts, 
although no prominent ER staining could be seen in immunostaining. The fact that Bmh1 and 
Bmh2 from single knockout strains can be ER- and Golgi-membrane localised shows that 
both homodimers are recruited to compartments that  are involved in the secretory pathway. 
No evidence could be found for differences in homodimer stability using Blue Native gel 
electrophoresis (BN-PAGE). All 14-3-3 isoforms formed stable homodimers and no exchange 
of 14-3-3 monomers was observed in the timeframe of the experiment. One has to emphasise 
critically  however, that the experiment was performed at a temperature of 4 ºC for 1 h, so that 
dissociation of homodimers could probably not occur. It has been furthermore suggested, that 
the balance between 14-3-3 homo- and heterodimers in vivo might be strongly regulated 
(Yaffe et  al., 2002). Meaning, that regulatory factors might be missing in dimerization studies 
performed in vitro.
Another putative explanation for isoform specificity are differences in binding affinities 
between  Bmh1 and Bmh2 and the Kir6.2 tail. Again, in vitro and in vivo experiments were 
combined to tackle the problem. Making use of the previously purified, untagged 14-3-3 
isoforms (see chapter 4.1) Isothermal calorimetry (ITC) was performed by K. Duderstadt 
(UCSF) to obtain binding affinities for the none-functional Bmh2 isoform to the Kir6.2-tail 
(see Fig. 17 A). As expected from previous work done by Yuan et  al, where only very weak 
interaction to monomeric presentation of the Kir6.2-tail could be observed (see Fig. 6C in 
Yuan et al., 2003), binding affinity to the monomeric version was not detectable by ITC. 
Using the tetrameric ccKir6.2 tail instead, resulted in detectable interaction and a dissociation 
constant of KD=6.2 nM, indicating very strong binding. This result underscores the 
preferential binding of 14-3-3 proteins to mutimerized presentation of the LRKR-Arg-based 
motif. In addition to ITC, I applied surface plasmon resonance (SPR) as a second quantitative 
method to determine dissociation constants for Bmh2 and Bmh1. Both methods complement 
each other very well. The advantage of SPR in comparison to ITC is that very low amounts of 
protein can be used and that binding can be directly observed. This allows direct 
determination of binding kinetics (association (on-) and dissociation (off-) rates) and gives 
additional information of the binding characteristics. The disadvantage of SPR is the 
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immobilization of the bait protein onto a planar surface, whereas ITC experiments are 
performed in buffer solution, without immobilization. Amount of immobilized bait protein, 
immobilization method and concentration range of ligand protein are crucial parameters to 
obtain useful results from SPR experiments and were therefore carefully adjusted. For both 
methods, data analysis was carried out under the assumption that only  14-3-3 dimers were 
present. This assumption was well verified by previous experiments (see text above).
First, I repeated binding of Bmh2 to the tetrameric tail. The resulting KD value (17.4 nM) was 
well in the range of the dissociation constant obtained by  ITC, confirming strong binding of 
Bmh2 to the ccKir6.2 tail. Surprisingly, the KD value for the functional Bmh1 isoform was 
very comparable (13.8 nM). Analogous results were obtained in vivo through co-
immunoprecipitation experiments (see Fig. 18), confirming the correctness and relevance of 
binding parameters that resulted from in vitro binding studies.
In summary, both yeast 14-3-3 isoforms are present on ER- and Golgi-enriched membranes 
and in the cytosol in similar amounts. No differences in binding affinities to the tetrameric 
reporter protein could be found in vitro and in vivo when the two isoforms are compared.
Taking into account, that overexpression of Bmh2 in a ∆bmh1 strain to the same total level of 
14-3-3 proteins as in wildtype did not rescue trafficking deficiency of the ∆bmh1 strain (see 
Fig. 15), the hypothesis of simple masking of the LRLR-motif by Bmh1 but not  Bmh2 can 
not be valid. Instead, other mechanisms must be responsible for isoform specific differences 
between Bmh1 and Bmh2. This will be discussed in the next paragraph.
5.2 Yeast 14-3-3 isoforms interact with a COPII component
Different hypothetical mechanisms for 14-3-3-dependent trafficking to the cell surface have 
been discussed (see Fig. 4; Mrowiec and Schwappach, 2006). Masking, a mechanism that is 
valid for a number of proteins including proteins that are involved in Ras and heterotrimeric 
G-protein signaling, or mitochondrial and nuclear proteins (see Fig. 2 for more examples), 
however, seems to be an insufficient hypothesis for multimeric membrane proteins. My 
results clearly demonstrate, that although equally present and binding the reporter with similar 
affinity, the non-functional Bmh2 isoform can not rescue trafficking defects of the ∆bmh1 
strain. In their recent work on K+ channels O’Kelly and Goldstein emphasize that masking of 
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a C-terminal COPI motif alone is not sufficient to promote efficient forward transport of 
TASK-1. Instead they show that 14-3-3s have to recruit p11, a protein that stimulates ER exit. 
Since p11 can not bind to the C-terminus of TASK-1 in absence of 14-3-3, they propose a 
scaffolding function of 14-3-3 in addition to masking a N-terminal COPI motif (O’Kelly and 
Goldstein, 2008). The same mechanism could be a plausible hypothesis for the observed 
isoform specific behavior observed for ccPmp2 trafficking in my  studies. Since both 14-3-3 
proteins were found on ER-enriched and Golgi-enriched membranes (see Fig. 20 B and C), 
the hypothesis that they  possibly recruit coat components or modulators of the early secretory 
pathway was tested using sequential stripping and pulldown experiments (see chapter 4.6). 
First, ER enriched membranes were sequentially  treated with KoAc, NaCl and Na2CO3 to 
concentrate putative interaction partners of either Bmh1 or Bmh2. To prevent dissociation of 
putative complexes, microsomes were first crosslinked with DSS and BMH crosslinker. 
Although two specific bands for Bmh1 (in the ∆bmh2 strain) and one Bmh2 specific band (in 
the ∆bmh1 strain) were identified, not all 14-3-3 proteins could be crosslinked as shown by 
the prominent 14-3-3 monomer bands in Figure 22. This could be explained by inaccessible 
reaction groups for the crosslink reagents. Furthermore, Coomassie staining to identify 
putative membrane associated reaction partners of 14-3-3 proteins was not possible, since no 
affinity purification step  was implemented. Alternative strategies must be performed in the 
future to identify  14-3-3 complexes on ER membranes: CO-IP experiments would allow 
specific affinity purification and enrichment of 14-3-3 complexes. To prevent dissociation of 
complexes, a crosslink treatment can be performed as a first step. Using Blue Native PAGE 
membrane protein complexes could be investigated in their native state. The advantage of this 
method is that no crosslinker treatment would be required. However, detergent-based 
solubilization of ER membranes in the experimental procedure could interfere with 14-3-3 
binding to putative interaction partners and facilitate dissociation of those complexes.
Some coat components like the COPII components Sec23/24 and Sec 13/31 are recruited 
from the cytosol to the membrane. To test whether 14-3-3 proteins bind to cytosolic 
interaction partners that  are possibly involved in trafficking of the Pmp2 reporter, a pulldown 
approach was chosen. 14-3-3 proteins were bound to the immobilized tetrameric Kir6.2 tail 
and incubated with yeast cytosol (see chapter 4.6.2). Unfortunately, no isoform specific bands 
were found. Still, one prominent, enriched band was identified by mass spectrometry as the 
COPII inner coat component Sec23 (see Fig. 23). This result  was complemented by 
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previously  published findings. In a large scale affinity-purification experiment Pozuelo Rubio 
and colleagues found an interaction of the yeast Bmh1 and Bmh2 isoforms with both Sec23 
isoforms (Sec23A and Sec23B) from HeLa cytosol (Pozuelo Rubio et al., 2004). The authors 
did not test  for isoform specific binding though, since both isoforms were immobilized on the 
Sepharose matrix together. Phosphorylation dependent mode-I, mode-II and mode-III binding 
motifs are the best described interaction sequences for 14-3-3 proteins (see Fig. 24 A). 
Besides Sec23A and Sec23B, Pozuelo Rubio et al identified more than 200 interactions 
partners for 14-3-3 Bmh1 and Bmh2 by eluting with a phosphopeptide that was competing for 
the binding pockets of 14-3-3s. This results suggests that most interactions involve binding of 
the phosphorylation dependent motifs. The most important feature of these motifs is the 
presence of a phosphorylated Serine or Threonine following an Arginine and a Proline residue 
at the end. None of these motifs is present in the sequence of yeast Sec23. However, many 
similar or alternative binding motifs have been shown to act as binding sites for 14-3-3s (see 
Yaffe et al., 2002). Thus, the consensus sequence was relaxed to three residues following the 
phosphorylated residue. As a consequence two putative motifs were identified in Sec23. 
Making use of a temperature sensitive sec23-1 strain, the mutants were expressed under 
permissive and restrictive temperatures where the temperature-sensitive allele is inactive. 
Both mutants alone and in combination supported growth of the temperature sensitive strain 
at the restrictive temperature, indicating that none of the mutants introduced a severe, global 
defect in comparison to wildtype (see Fig. 25). However, localization of the ccPmp2 reporter 
was strongly influenced by  the mutations (Fig. 26). The effects were additive, so that the 
reporter was completely mislocalized and could not be found in the vacuole anymore in the 
double mutant (see Fig. 26, S79N/S726N panel). This result was surprising, because reporter 
trafficking was crucially  affected by the Sec23 mutants, whereas general growth was 
comparable to a wildtype strain. The finding suggested that the mutated Sec23 sites are 
specifically involved in trafficking of the Pmp2 reporter, but  do not create general trafficking 
defects. To investigate if loss of Bmh1 is specific for a subgroup of proteins, localization of 
three different cargo proteins was observed in the ∆bmh1 strain (Fig. 31). Only  cycling cargo 
was found to be affected by the loss of Bmh1. This provides a possible link between 14-3-3 
Bmh1 and COPII coat  components and implies the idea, that 14-3-3 proteins have a 
regulatory role in forward trafficking for this class of recycling proteins and do not influence 
trafficking in a more general way. So far, regulation of COPII vesicle formation has been 
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suggested to be controlled by cargo recognition and sequentially  increasing GTPase activity 
(Antonny et al. 2001; Miller et al., 2003; Sato and Nakano, 2007), thus by regulation of the 
kinetics of vesicle formation. Recent studies on the structure of the COPII coat add a new 
mechanism of regulation, since they suggest sterical control of vesicle formation through 
flexible coordination of coat components (see Stagg et al., 2006 and 2008). The findings that 
outer coat components Sec13/31 interact with inner coat components (Sec23/24-Sar1) and 
Sec13/31 is arranged to adapt to specific cargo, suggest new roles for regulatory factors. 
To further investigate the putative link between trafficking defects specific for cycling cargo 
in the ∆bmh1 knockout and trafficking defects with Sec23 mutations, I suggest using live cell 
imaging for localization studies of GFP-tagged cycling and non-cycling cargo (ccPmp2-
RERS reporter versus CPY and Gef1) in the temperature sensitive sec23-1 strain expressing 
either one or both Sec23 mutants under restrictive temperature. A pulldown approach with the 
Sec23 mutants can be used to test if binding of 14-3-3 to Sec23 depends on the presence of 
the mutated residues. Using either an ATP-regeneration system or λ-phosphatase in the 
pulldown could answer the question if binding is phosphorylation dependent. Those 
experiments can be complemented by co-immunoprecipitation experiments to test for in vivo 
interaction of 14-3-3s and Sec23 mutations. 
5.3 Small differences in the distal C-termini create isoform 
specificity
All 14-3-3 proteins share a common structure and very  similar sequences. Especially the yeast 
isoforms are highly similar (see Fig. 27 A). The highest sequence diversity can be found in the 
14-3-3 C-termini. Do small differences in the Bmh1 and Bmh2 C-termini correlate with 
isoform specificity? I swapped the last 69 amino acids of Bmh1 with the last 75 amino acids 
of Bmh2 and vice versa. The advantage of having a defined isoform specific effect and the 
fact that only two isoforms are present in yeast made it possible to show, that only the Bmh1 
C-terminus is able to promote forward transport (see Fig. 27 B). The result that the chimeric 
H2N1C isoform did promote forward transport is consistent with the idea that the distal C-
terminal parts of yeast 14-3-3 proteins exert their effects independently of dimerization or 
binding pocket formation and are an independent interaction region. This hypothesis has been 
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discussed by other groups as well, since it was found that the C-termini are a very flexible 
region of 14-3-3 proteins (see Obsilova et  al., 2008 for review). Roth and colleagues for 
example showed in yeast that overexpression of the carboxy-terminal region of Bmh2 but not 
Bmh1 was lethal (Roth et al., 1999). Although the authors do not give an mechanistic 
explanation, they speculate that binding to additional downstream partners could explain 
isoform specificity. My observations and these findings gave me reason to perform pulldown 
experiments with the distal C-termini of Bmh1 and Bmh2 to search for putative, specific 
binding partners. Again, no isoform specific bands could be identified. However, a small 15 
kDa protein was highly enriched from yeast cytosol. Mass spectrometry analysis identified 
the protein as Ndk1 (nucleoside diphospohate kinase). I was able to confirm the interaction by 
immunoblotting and showed that it is direct (see Fig. 28). Ndk1 is best described for its 
enzymatic function in creating GTP from GDP and ATP (Agarwal et al., 1978; Jong and Ma, 
1991; Fukuchi et  al., 1993). GTP is required to initiate COPI and COPII vesicle formation, 
therefore Ndk1 seemed a very  interesting protein to potentially  participate in the regulation of 
trafficking by  controlling local availability  of GTP (see Fig. 38 B). In addition, recent work 
connected the human homolog of Ndk1, Nm23H2, to COPII vesicle formation in mammalian 
cells (Kapetanovich et al., 2005). The authors identified Nm23H2 from mammalian cytosol in 
a sequential multi-step purification procedure as a regulator of COPII assembly. They made 
use of a COPII assembly  assay in digitonin-permeabilized cells to show stimulation of ER 
exit site formation in Nm23H2 presence. Knockdown of Nm23H2 lead to reduced COPII 
assembly. 
For those reasons I decided to follow up the connection between 14-3-3s and Ndk1 and a 
possible role of the interaction in forward trafficking.
5.4 14-3-3 Bmh1 as regulator of COPII vesicle formation
My findings that yeast 14-3-3 proteins interact with the COPII component Sec23 and my 
pulldown experiments identifying Ndk1 (that  has previously been described to be involved in 
efficient COPII vesicle formation in mammalian cells) as a putative 14-3-3 binding partner 
motivated me to investigate the role of yeast 14-3-3s in COPII budding in detail. I made use 
of an in vitro budding assay  that  has the advantage to uncouple COPII vesicle formation from 
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other trafficking effects that  occur in vivo. In contrast to steady state localization studies in 
vivo, the in vitro assay allows mechanistic studies in a controlled environment. Together with 
the possibility to combine ER enriched membranes from different yeast knockout strains with 
different yeast  cytosols, the COPII budding assay turned out to be a powerful tool for 
mechanistic investigations adressing the role of 14-3-3 and Ndk1 in vesicle formation. 
Comparison of wildtype, ∆bmh1 and ∆bmh2 conditions revealed a big difference in the ability 
of Bmh1 and Bmh2 to promote COPII budding (Fig. 30 B). Lack of Bmh1 resulted in poor 
packaging and no detectable Sec24 on budded vesicles. Surprisingly, the strong effect did not 
only apply to the tetrameric reporter, but also to Emp47, a cargo protein, that has no 14-3-3 
binding motif. The second surprising outcome was, that cytosolic Bmh1 could not rescue 
packaging defects of the ∆bmh1 strain. On the other hand, lack of Bmh1 in the ∆bmh1 cytosol 
reduced Sec24 recruitment by  ~50% when Bmh1 was present on the microsomes only  (see 
Fig. 30 C). To further separate both effects, I performed the same budding assays with and 
without addition of purified Bmh1 (see Fig. 33). Adding purified Bmh1 to a budding assay 
where only Bmh2 microsomes and Bmh2 cytosol were used, resulted in clearly  stimulated 
packaging. However, no increase in Sec24 recruitment was observed. In contrast, vesicle 
formation relying on Bmh1 microsomes and Bmh2 cytosol lead to efficiently recruited Sec24 
but only poor packaging. In summary, a dual role for Bmh1 was observed in COPII budding 
experiments. Strong presence of Sec24 on budded COPII vesicles originating from Bmh1 
containing donor membranes suggests a membrane associated role of Bmh1 on ER 
membranes. 14-3-3 Bmh1 may have a role in structural co-ordination of coat components, or 
in stabilisation of the inner coat. The observed interaction with Sec23 strengthens this 
hypothesis. In addition, cytosolic Bmh1 could be responsible for the recruitment of regulatory 
components to ER exit sites. Ndk1, which was shown to interact with the 14-3-3 C-termini 
was a good candidate to potentially mediate the isoform specific role of Bmh1. Therefore 
COPII budding assays with ER membranes from the ∆ndk1 strain were compared to wildtype 
budding (Fig. 35). Unexpectedly, COPII vesicle formation from a Ndk1 deletion strain was 
highly  efficient and very comparable to wildtype. This finding is controversial when 
comparing to data by  Kapetanovich et al, where knockdown of Nm23H2 lead to reduced ER-
exit kinetics of GalNacT2-GFP (Kapetonovich et  al., 2005). As the loss of Ndk1 was not 
crucial for COPII budding, I asked if knockout of Ndk1 and Bmh1 or Bmh2 in combination 
influences vesicle formation. To further separate the exact functions of the three proteins I 
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performed the budding reaction under various conditions (see Fig. 36). The first unexpected 
finding was that Sec24 was strongly present on vesicles and cargo packaging was very 
efficient in the ∆ndk1∆bmh1 strain. This result  implies a positive role in COPII budding for 
Bmh2 alone, but a putative negative complex when Bmh2 and Ndk1 are expressed together 
(compare budding results from ∆bmh1 strain, Fig. 30 B). The very opposite result was 
obtained for budding of the ∆ndk1∆bmh2 strain. No vesicle formation was observed in the 
presence of Bmh1 alone. Efficient packaging was induced upon addition of Ndk1 or the 
enzymatically inactive Ndk1 mutant, even without adding purified Sar1 protein (see Fig. 36 
C). In conclusion, Bmh1 and Ndk1 act in combination to enhance packaging. Together they 
seem to form a highly stimulating complex and promote COPII vesicle formation even in the 
presence of low amounts of cytosolic Sar1 (see cartoon in Figure 38 A). 
How can Bmh1-Ndk1 form a promoting complex, if affinity  of Bmh1 and Bmh2 C-termini to 
Ndk1 was shown to be similar? A possible explanation could be differences in in vitro binding 
and in vivo binding of 14-3-3s to Ndk1. In my pulldown experiment only  the distal C-termini 
were exposed. Several groups however reported that flexible C-termini can regulate the 
binding of 14-3-3s to interaction partners in vivo (Obsilova et al., 2004, Silhan et al., 2004). 
The suggested explanation is, that a flexible 14-3-3 C-terminus can autoinhibit the 14-3-3 
binding groove. This inhibition is controlled by  phosphorylation (Silhan et al., 2004). Truong 
and colleagues observed a lowered affinity  of 14-3-3s to binding partners in presence of their 
C-termini (Truong et al., 2002). It might be, that 14-3-3 Bmh1 and Bmh2 can perform the 
A B
Figure 38: 
(A) Model of 14-3-3-Ndk1 influence on COPII vesicle formation.
14-3-3 Bmh1 requires Ndk1 to stimulate COPII budding, whereas Bmh2 in the presence of  Ndk1 (membrane 
bound?) inhibits COPII budding. A ∆ndk1∆bmh1 strain was very efficient in COPII vesicle formation, indicating a 
positive role of Bmh2 in the absence of Ndk1.
(B) Cartoon showing the putative connection between Ndk1 enzyme activity and COPII budding.
The hypothesis that Ndk1 enzyme activity (GTP production) could create a local pool of high GTP concentration 
and by this promote COPII vesicle formation was excluded by using a catalytically inactive mutant, that was as 
efficient as the active Ndk1 version in stimulation of COPII budding (see Fig. 36). 
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same binding to Ndk1 in vitro, but their binding-unbinding dynamics in vivo are modulated by 
different C-termini interactions with their binding groove.
Consistent with results presented by  Kapetanovich and colleagues, Ndk1 stimulation does not 
depend on its enzymatic activity, as shown by efficient budding of the ∆ndk1∆bmh2 strain 
with addition of the mutant Ndk1 version. This means, that the hypothesis of Ndk1 increasing 
the local GTP availability  for regulation of vesicle budding is not valid (see cartoon in Fig. 38 
B).
5.5 Speculations and outlook
14-3-3 proteins were found to act as regulator proteins of COPII vesicle formation. Putative 
binding sites were identified in Sec23 and mutation of these phosphorylation dependent 
motifs on Sec23 resulted in mislocalization of the ccPmp2 reporter protein. Although a direct 
in vivo interaction between yeast 14-3-3s and Sec23 has still to be proven, a regulatory role in 
inner coat assembly and stabilization could be a mechanism by which 14-3-3s promote 
forward transport in a isoform specific way. This hypothesis is supported by the fact, that the 
∆bmh1 strain shows a strongly reduced presence of Sec24 on ER enriched membranes. 
Furthermore, membrane bound 14-3-3 Bmh1, but not Bmh2, strongly enhances Sec24 
presence on budded vesicles. 
Bmh1 needs Ndk1 for its stimulatory function. The fact, that  addition of Ndk1 to the budding 
reaction strongly promotes vesicle formation from ∆bmh2 microsomes even in the presence of 
only low amounts of cytosolic Sar1, suggests a structural role for the Bmh1-Ndk1 
combination. A similar speculation was also formulated by Kapetanovich and colleagues for 
the COPII promoting function of the human Ndk1 homolog Nm23H2. Recent findings by 
Stagg et al present a new idea for COPII regulation in which a flexible hinge region adjusting 
the geometry of outer coat components Sec13/31 and their binding to Sec23/24-Sar1 could be 
an interaction surface for various regulatory  proteins. Bmh1 in combination with Ndk1 could 
act in this way. Similar examples have been reported lately, Higashio et al identified Smy2 as 
a modulator of the Sec23/24 inner coat (Higashio et al., 2008). 
The region of yeast 14-3-3 Bmh1 necessary for forward transport stimulation was narrowed 
down to its C-terminus. Although Bmh1 and Bmh2 C-termini showed similar affinity for 
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Ndk1 in pulldown experiments, isoform specificity in vivo could be explained by  regulation 
of flexible C-termini and 14-3-3 binding groove interactions as discussed above. The idea, 
that 14-3-3 Bmh1 and Bmh2 differ significantly in their native protein structure is supported 
by Blue Native PAGE where the 14-3-3 protein bands, which run at the height of a dimer, 
differ significantly in their running behavior, while the monomers differ only  by 1-3 kDa in 
size (see Fig. 39).
Taking the data obtained in my study  together, one has to conclude, that simple masking of 
the Arg-based COPI recognition motif by 14-3-3 proteins is not a sufficient explanation for 
the observed isoform specificity. Instead, a regulatory function of 14-3-3 proteins in the 
forward trafficking of KATP channels at the level of COPII vesicle formation can be proposed. 
Further investigations of the interaction between 14-3-3s and COPII inner coat components 
are necessary though. The yeast system remains a powerful tool for further experiments, since 
it allows the expression of mutated COPII components in temperature sensitive strains, where 
essential genes are downregulated and offers the possibility  to generate ER enriched 
membranes and cytosol from various knockout strains. 
Ndk1 was identified as a putative interaction partner of yeast 14-3-3 proteins that was 
necessary  to stimulate COPII budding in vitro. The human homolog of Ndk1 was recently 
connected to changes in ER morphology (Baughman et al., 2008) through lipid binding. 
Electron microscopy could be used as an approach to test  for Ndk1 induced changes in ER 
exit site morphology. Temmermann and colleagues presented a new assay based on flow-
Figure 39: 14-3-3 Bmh1 and Bmh2 are present on 
microsomes as dimers that differ significantly in 
their running behavior on Blue Native PAGE gels.
Microsomes of ∆bmh1 and ∆mbh2 strains (200 µg of 
total protein) were solubilized in buffer A or buffer B (see 
buffer list for more details) and either Dodecyl β-D 
maltoside (DoDm) or digitonin (dig.) for 30 min on ice. 
Then microsomes were separated under native 
conditions on Blue Native PAGE, blotted and detected 
with anti-bmh antiserum.
Although Bmh2 and Bmh1 differ only by 1 kDa in size, 
they show significantly different running behavior under 
native conditions.
(Experiment performed by E. Arakel.)
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cytometry  that allows investigation of lipid binding by fluorescently labelled proteins 
(Temmermann et al., 2009, in press). This method could be adopted to investigate binding of 
Ndk1 and complexes of Ndk1 and either Bmh1 or Bmh2 to liposomes resembling ER or 
Golgi membranes in lipid composition. 
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Abbreviations
A  ampere
AA  amino acid
ABC   ATP-binding cassette
Amp   Ampicilin
AP   alkaline phosphatase
APS   ammonium persulfate
Arf   ADP ribosylation factor 1
ATP/ADP  adenosine tri/diphosphate
ATPase adenosine triphosphatase
BiP   immunoglobulin heavy chain-binding protein
BSA  bovine serum albumin
bp   base pair
C-terminus carboxyl-terminus
CCVs   Clathrin-coated vesicles
cDNA   complementary DNA
CGN   cis-Golgi network
COPI/II  coatomer protein I/II
DMSO  dimethyl sulfoxide
DNA  Deoxyribonucleic acid
dNTPs  deoxyribonucleotide triphosphates
dox   doxycycline
DSS   disuccinimidyl suberate
DTT   dithiothreitol
EDTA  ethylenediaminetetraacetic acid
ER   endoplasmic reticulum
ERAD  ER-associated degradation
ERES  ER exit sites
ERGIC ER-Golgi intermediate compartment (VTC)
et al.  et alii
e.g.  for example
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FACS  fluorescence-activated cell sorting
g  gram
GAP   GTPase-activating protein
GDP/GTP guanosine di/triphosphate
GEF   guanine exchange factor
GFP   green fluorescent protein
Glc   glucose
h  hour
Hepes   N-2-hydroxyoxyethylpiperazine-N’-2-ethane sulfonic acid
HRP   horse radish peroxidase
IPTG    isopropylthio-β-D-galactoside
in vitro in a controlled environment outside of a living organism
in vivo  inside an organism or living tissue
Kan   Kanamycin
KATP  ATP-sensitive potassium channel
kb   kilo-base pair
kDa   kilo-Dalton
KDEL  Lysine-aspartic acid-glutamic acid-leucine
Kir   inwardly rectifying potassium channel
l  liter
LB  Luria-Bertani
m  milli
M  molar
min  minute
mRNA messenger RNA
µ  micro
N-   amino-
nm  nanometer
oN  over night
PAGE  Polyacrylamide gel electrophoresis
PBS   Phosphate-buffered Saline
PCR   Polymerase chain reaction
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PM   plasma membrane
PMSF   phenylmethylsulfonyl fluoride
RKR / R-based signal  arginine-based ER localization signal
RNA  Ribonucleic acid
rpm   revolutions per minute
RU  Response Unit (BiaCore unit)
S/T   serine/threonine
s  second
SDS   sodium dodecyl sulphate
SDS-PAGE  SDS-polyacrylamide gel electrophoresis
SNARE  SNAP receptor
SUR   sulfonylurea receptor
TBS   Tris-buffered Saline
TEMED  tetrametyhylethylene diamine
tet   tetrocycline
TGN   trans-Golgi network
TM   transmembrane segment
TMD   transmembrane domains
Tris  Tris-(hydroxymethyl)aminomethane
U  unit
V  volt
vac  vacuole
VTC  Vesicular-tubular cluster (ERGIC)
v/v  volume per volume
w/v  weight per volume
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